{
  "meta": {
    "title": "175_Dermatology_Ini-Cet_2022",
    "url": "https://brainandscalpel.vercel.app/175-dermatology-ini-cet-2022-32c84edd.html",
    "scrapedAt": "2025-11-30T12:56:34.251Z"
  },
  "questions": [
    {
      "text": "A 10-year-old boy presents with fever, joint pain, and a lesion over his hand as seen in the image below. Which of the following is the clinical finding given and what is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Gottron's papules - Juvenile dermatomyositis"
        },
        {
          "id": 2,
          "text": "Rheumatoid nodules - Juvenile rheumatic arthritis"
        },
        {
          "id": 3,
          "text": "Sclerodactyly - Systemic sclerosis"
        },
        {
          "id": 4,
          "text": "Mechanic's hand - Systemic lupus erythematosus"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given image showing erythematous papules over dorsal metacarpophalangeal and interphalangeal joints (<strong>Gottron&rsquo;s papules</strong>) is a characteristic skin lesion seen in <strong>dermatomyositis&nbsp;(DM)</strong>. Fever and joint pain (arthralgia) are non-specific complaints.</p>\n<p>DM is an inflammatory myopathy affecting skin and skeletal muscle. DM can be seen in children (juvenile DM) or in adults. It presents with symmetric, <strong>proximal</strong> more than distal <strong>muscle weakness</strong> associated with characteristic skin manifestations:</p>\n<ul>\n<li><strong>Heliotrope rash</strong>: Lilac erythema of eyelids with periorbital edema</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c38ff86cefc04031b69ec9c2b9497d08x768x305.JPEG\" alt=\"Explanation Image\"><ul>\n<li><strong>Gottron&rsquo;s papules</strong>: Violaceous, flat‐topped papules on the skin overlying the interphalangeal joints and metacarpophalangeal joints</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2d18d2831fa54e98b4b3fbb9de281209x281x240.PNG\" alt=\"Explanation Image\"><ul>\n<li><strong>Gottron sign</strong>: Erythematous rash over the extensor surfaces of joints such as the knuckles, elbows, knees, and ankles</li>\n<li><strong>V-sign</strong>: Erythematous macules over anterior chest</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/532ee519df5240c48206d3239d543d08x768x423.JPEG\" alt=\"Explanation Image\"><ul>\n<li><strong>Shawl sign</strong>: Erythematous macules over posterior neck and upper back</li>\n<li>Mechanic's hand: Roughening and cracking of the skin of the tips and sides of the fingers, resulting in irregular, dirty-appearing lines that resemble those of a mechanic or manual laborer</li>\n<li><strong>Nail bed telangiectasias</strong></li>\n<li>Subcutaneous calcium deposits</li>\n</ul>\n<p>DM is associated with <strong>interstitial lung diseases</strong> (ILD) and <strong>internal malignancies</strong>, most commonly adenocarcinomas. Adult onset DM has a stronger association with malignancies.</p>\n<p>Laboratory evaluation of patients with dermatomyositis will reveal&nbsp;<strong>elevated serum creatinine kinase</strong>&nbsp;and&nbsp;<strong>antinuclear antibodies</strong>. Electromyography will reveal features of myopathy. Histology will show&nbsp;<strong>perifascicular atrophy.</strong> Immunohistochemical staining will reveal&nbsp;<strong>myxovirus resistance protein A</strong>, a sensitive and specific marker.&nbsp;</p>\n<p>Treatment of dermatomyositis is include:</p>\n<ul>\n<li>Immunotherapy with&nbsp;<strong>high-dose glucocorticoids</strong>&nbsp;- first-line drug</li>\n<li><strong>Methotrexate</strong>&nbsp;-&nbsp;<strong>second line</strong>&nbsp;drug. Indications include -\n<ul>\n<li>When patient presents with severe weakness, or other organ system involvement</li>\n<li>Patients with risk of steroid complications like patients with diabetes, osteoporosis, or postmenopausal women</li>\n<li>Patients who do not show improvement after 2-4 months of treatment with prednisone or those who cannot be maintained on a low dose&nbsp;</li>\n</ul>\n</li>\n<li><strong>Triple therapy</strong>&nbsp;with&nbsp;<strong>intravenous immunoglobulin&nbsp;</strong>or<strong>&nbsp;rituximab</strong>&nbsp;may be required</li>\n</ul>\n<p>The prognosis is favourable in the absence of associated ILD or malignancies.</p><hr><h3>Related Pearl: Antibodies in Dermatomyositis</h3><ul>\n<li><strong>Anti-Mi2 antibodies</strong> (directed against a helicase implicated in nucleosome remodeling) show a strong association with prominent Gottron papules and heliotrope rash.</li>\n<li><strong>Anti-Jo1 antibodies</strong> (directed against the enzyme histidyl t-RNA synthetase) are associated with interstitial lung disease, nonerosive arthritis, and a skin rash described as &ldquo;mechanic&rsquo;s hands.&rdquo;</li>\n<li><strong>Anti-P155/P140 antibodies</strong> (directed against several transcriptional regulators) are associated with paraneoplastic and juvenile cases of dermatomyositis.</li>\n</ul><hr><h3>Related Pearl: Inflammatory myopathy</h3><table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Dermatomyositis</strong></td>\n<td><strong>Polymyositis</strong></td>\n<td><strong>Inclusion Body Myositis</strong></td>\n</tr>\n<tr>\n<td>Age of onset</td>\n<td>Adulthood and childhood</td>\n<td>&gt;18 years</td>\n<td>&gt;50 years  </td>\n</tr>\n<tr>\n<td>Familial Association</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Skin Manifestation</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Muscle involvement</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Asymmetric</p>\n</td>\n</tr>\n<tr>\n<td>Histopathological Findings</td>\n<td>\n<p><strong>Perimysial</strong> <strong>CD4+</strong> cellular infiltrates</p>\n<p>Perivascular infiltrates and <strong>perifascicular atrophy</strong></p>\n</td>\n<td>\n<p><strong>Endomysial</strong> <strong>CD8+</strong> cellular infiltrates </p>\n<p>Perivascular infiltrates  </p>\n</td>\n<td>\n<p><strong>Endomysial</strong> <strong>CD8+</strong> cellular infiltrates</p>\n<p>Perivascular infiltrates with amyloid inclusion bodies and rimmed vacuoles   </p>\n</td>\n</tr>\n<tr>\n<td>Association with connective tissue disease</td>\n<td>Scleroderma and mixed connective tissue only</td>\n<td>Yes</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Association with other autoimmune diseases</td>\n<td>Infrequent</td>\n<td>Frequent</td>\n<td> Infrequent</td>\n</tr>\n<tr>\n<td>Association with malignancy</td>\n<td>Yes (breast, ovarian, lung) and ILD</td>\n<td> Yes (incidence much lesser than dermatomyositis)</td>\n<td> No</td>\n</tr>\n<tr>\n<td>Immunotherapy</td>\n<td> Responsive</td>\n<td> Responsive</td>\n<td> Resistant</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/97027f2b362b4481b06e4ad54900354c.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4914",
      "difficulty": "easy"
    },
    {
      "text": "A 12-week pregnant woman who is already on multidrug therapy for leprosy presents with type 2 lepra reaction. What is the treatment of choice for this patient?<div class='question-desc-html'><p>(MDT -&nbsp;multidrug therapy)</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Stop MDT and start oral steroids"
        },
        {
          "id": 2,
          "text": "Antibiotics"
        },
        {
          "id": 3,
          "text": "Thalidomide"
        },
        {
          "id": 4,
          "text": "Continue MDT and add oral steroids"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The treatment of choice for a <strong>pregnant</strong> lady with <strong>type 2 lepra</strong> reaction is to <strong>continue multidrug therapy (MDT)&nbsp;</strong>and <strong>start oral steroids</strong>.&nbsp;MDT is <strong>not stopped</strong> in lepra reactions. MDT is proven to be<strong> safe</strong>&nbsp;in pregnancy.&nbsp;Thalidomide is contraindicated (especially in the 1st trimester) due to the risk of teratogenic changes in the fetus (phocomelia).</p>\n<div class=\"page\" title=\"Page 1428\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Type 2 lepra reaction</strong> or<strong> erythema nodosum leprosum</strong>&nbsp;(ENL) is an immune complex-mediated syndrome&nbsp;(<strong>type 3 hypersensitivity</strong>) affecting the skin, nerves, and other organs. It is&nbsp;mainly seen in the multibacillary form of leprosy and is commonly recurrent. It usually occurs during treatment, but can also be seen before or after treatment.</p>\n<p>ENL presents with acute onset, painful, erythematous nodules on the face and<strong>&nbsp;extensor surfaces</strong>&nbsp;of limbs that blanch on pressure.&nbsp;<strong>Systemic manifestations</strong>&nbsp;include fever, malaise, anorexia, neuritis, uveitis, dactylitis, arthritis, myositis, etc. can also be seen.&nbsp;</p>\n<p><strong>Treatment</strong>&nbsp;includes:</p>\n<ul>\n<li><strong>Thalidomide&nbsp;</strong>is the drug of choice in young men with severe or recurrent ENL. It is <strong>contraindicated</strong> during <strong>pregnancy</strong> due to its high <strong>teratogenicity </strong>causing <strong>phocomelia</strong>. Even in women of reproductive age, it is given with caution.</li>\n<li><strong>Glucocorticoids</strong>&nbsp;(high doses) are routinely used in all patients and help in <strong>suppressing</strong> the acute signs and symptoms of inflammation.&nbsp;</li>\n<li><strong>Clofazimine</strong> is useful as long-term maintenance therapy for <strong>preventing recurrent reactions</strong>. Clofazimine is not given to this patient because it is already a part of the MDT regimen containing dapsone,&nbsp;rifampicin, and clofazimine.</li>\n</ul>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Lepra Reactions</h3><p><strong>Lepra Reactions:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type 1 Reaction</strong></p>\n<p>(Reversal/Upgrading)</p>\n</td>\n<td>\n<p><strong>Type 2 Reaction</strong></p>\n<p>(Erythema Nodosum Leprosum)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mainly seen in the&nbsp;<strong>Borderline</strong> spectrum (BT, BB, BL)</p>\n<p><strong>Most severe</strong> in Borderline Lepromatous(BL) leprosy</p>\n</td>\n<td>Mainly seen in <strong>LL</strong>(50%)&gt;BL(15%)</td>\n</tr>\n<tr>\n<td>\n<p>Usually seen <strong>within 12 months</strong> of initiation of Multidrug Therapy</p>\n</td>\n<td><strong>Unrelated</strong> to Multidrug therapy. May occur before, during or after treatment</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type 4</strong> Hypersensitivity</p>\n<p>Due to <strong>enhanced cell-mediated response</strong>&nbsp;increased destruction of bacilli following treatment in reversal</p>\n</td>\n<td>\n<p><strong>Type 3</strong> Hypersensitivity</p>\n<p>Primarily Humoral</p>\n<p>(<strong>Immune complex Deposition</strong> in tissues and vessels)</p>\n<p>Cytokine involved - <strong>TNF-&alpha;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inflammation of <strong>existing skin lesions</strong> (red, painful edematous skin lesions) that may <strong>ulcerate</strong></p>\n<p>New lesions may occur (rare)</p>\n<p><strong>Neuritis</strong>&nbsp;and <strong>Nerve abscesses&nbsp;</strong>(red, painful inflamed nerves)</p>\n</td>\n<td>\n<p><strong>New, erythematous and tender</strong>, subcutaneous and dermal nodules that are widely distributed over extremities and face</p>\n<p>Existing lesions do not change</p>\n</td>\n</tr>\n<tr>\n<td><strong>No</strong> systemic involvement</td>\n<td><strong>Systemic symptoms</strong> present - fever, myalgias, arthralgias, anorexia, keratitis, iritis, nephritis, synovitis, orchitis, lymphadenopathy</td>\n</tr>\n<tr>\n<td>\n<p><strong>Treatment:</strong></p>\n<p>Supportive therapy for mild reactions with <strong>NSAIDs</strong></p>\n<p>In case of severe reactions with neuritis and eye lesions- <strong>Oral corticosteroids</strong></p>\n<p><strong>(Drug of Choice)</strong></p>\n<p>Nerve Abscess - Additional <strong>surgical drainage</strong></p>\n<p>Other drugs: Clofazimine, Cyclosporine</p>\n</td>\n<td>\n<p><strong>Treatment:</strong></p>\n<p><strong>Oral Corticosteroids - First-line drug<br /><br />Clofazimine </strong>(Steroid dependent ENL)<strong><br /></strong></p>\n<p><strong>Thalidomide -most effective </strong>but not used first due to various side effects</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4962",
      "difficulty": "easy"
    },
    {
      "text": "A patient presents to the outpatient department with a satellite skin lesion. On examination, he has one hypopigmented lesion and one thickened nerve. Images of two blister packs are given below. The treatment best suited for this patient would be:",
      "choices": [
        {
          "id": 1,
          "text": "Packet 1 for 12 months"
        },
        {
          "id": 2,
          "text": "Packet 2 for 12 months"
        },
        {
          "id": 3,
          "text": "Packet 1 for 6 months"
        },
        {
          "id": 4,
          "text": "Packet 2 for 6 months"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The treatment best suited for this patient would be <strong>packet 2-maroon </strong>for<strong> 6 months</strong>. The clinical scenario of <strong>one hypopigmented satellite skin lesion</strong> and <strong>one thickened nerve</strong> suggests <strong>paucibacillary leprosy</strong>. The treatment of paucibacillary leprosy (PB) is multidrug therapy (MDT) with <strong>rifampicin</strong>, <strong>dapsone, </strong>and<strong> clofazimine </strong>which is the<strong> maroon </strong>blister packet for 6 months.</p>\n<p>The <strong>current recommendation by WHO</strong> is to treat <strong>PB </strong>leprosy with a combination of <strong>3 drugs </strong>- rifampicin, dapsone, and clofazimine (maroon blister pack) for<strong> 6 months. </strong>Meanwhile,<strong> multibacillary </strong>(MB)<strong> </strong>leprosy is treated using the same <strong>3 drugs</strong> for a duration of <strong>12 months. </strong>While the NLEP guidelines earlier mentioned a 2-drug MDT for PB leprosy, the <strong>National Strategic Plan and Roadmap for Leprosy (2023-2027)</strong> now recommends a <strong>uniform MDT of 3 drugs</strong> for both PB and MB leprosy.</p>\n<p>Management of leprosy is based on the bacterial load. WHO defines <strong>PB </strong>disease as the presence of no bacilli on smears or biopsy and <strong>less than or equal to 5 skin lesions</strong> with no or only one peripheral nerve involved. <strong>MB</strong> leprosy<strong> </strong>is characterized by bacilli on smears or biopsies of <strong>more than 5 skin lesions </strong>and more than 1 peripheral nerve involvement.</p>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;The manifestations of leprosy depend on the immune response of an individual to the bacillus Mycobacterium leprae. A single skin lesion may develop in an exposed person who is susceptible to leprosy, after an incubation period. This initial stage is called indeterminate leprosy.\\nThe lesions of indeterminate leprosy tend to be hypopigmented and ill-defined, and they heal on their own in approximately 75% of cases(Option D). &quot;}\" data-sheets-userformat=\"{&quot;2&quot;:513,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0}\">The image given below shows a hypopigmented satellite skin lesion seen in leprosy.</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/043e8d80f09d40cfac5f975f0baaca64x367x512.JPEG\" alt=\"Explanation Image\"><div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p><strong>Chemoprophylaxis</strong> for leprosy should be given in those</p>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Age more than 2 years</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Close contact for more than 20 hours per week for more than 3 months</span></li>\n</ul>\n<p>A <strong>single dose of rifampicin</strong> is recommended for the close contact of a patient with leprosy provided they do not develop any signs or symptoms pertaining to leprosy.</p><hr><h3>Related Pearl: Characteristics of Ridley Jopling Classification in Leprosy</h3><table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>TT (Tuberculoid Leprosy)</strong></td>\n<td><strong>BT (Borderline Tuberculoid)</strong></td>\n<td><strong>BB (Borderline)</strong></td>\n<td><strong>BL(Borderline Lepromatous)</strong></td>\n<td><strong>LL (Lepromatous Leprosy)</strong></td>\n</tr>\n<tr>\n<td><strong>Number and Type of lesions</strong></td>\n<td><strong>1-3</strong> <strong>well</strong><br /><strong>defined</strong> hypopigmented macule(s) or plaque(s) with elevated sloping borders '<strong>saucer right side up'</strong> lesion. Asymmetrical distribution.</td>\n<td>\n<p>Hypopigmented macules or plaques, variable in number, up to <strong>10</strong>.</p>\n<p>Occasionally showing fingerlike extensions<br />(<strong>pseudopodia</strong>) or <strong>satellite lesions</strong></p>\n</td>\n<td>\n<p>Hypopigmented macules or plaques with annular, ‘<strong>swiss </strong><strong>cheese’</strong> /inverted saucer/punched out appearance</p>\n<p>Variable in number<br /><strong>(10–30)</strong></p>\n</td>\n<td>\n<p><strong>Numerous</strong> hypopigmented macules, papules, plaques, and some nodules, lesions with <strong>swiss </strong><strong>cheese’</strong> /inverted saucer/punched out appearance <strong>almost symmetrical</strong> in<br />distribution</p>\n</td>\n<td>\n<p>Hypopigmented macules, plaques,<br />and nodular lesions</p>\n<p><strong>Innumerable</strong> lesions<br />showing <strong>perfect  symmetrical </strong>distribution</p>\n</td>\n</tr>\n<tr>\n<td><strong>Size of Lesion</strong></td>\n<td>Variable size,<strong>usually</strong><br /><strong>large</strong></td>\n<td>Variable size, some lesions are large</td>\n<td>Variable</td>\n<td>Variable, usually small</td>\n<td><strong>Small</strong></td>\n</tr>\n<tr>\n<td><strong>Surface of Lesion</strong></td>\n<td><strong>Dry, scaly and infiltrated</strong></td>\n<td>Dry, scaly infiltrated (but less than TT)</td>\n<td>Dry, scaly and slightly shiny</td>\n<td>Shiny (less than LL)</td>\n<td><strong>Shiny</strong></td>\n</tr>\n<tr>\n<td><strong>Sensations</strong></td>\n<td><strong>Absent. </strong></td>\n<td>Markedly diminished</td>\n<td>Moderately diminished</td>\n<td>Slightly diminished</td>\n<td><strong>May be normal</strong></td>\n</tr>\n<tr>\n<td><strong>Peripheral Nerves</strong></td>\n<td>\n<p><strong>Asymmetrical, single nerve</strong><br />enlargement.</p>\n<p>Nerve to patch may<br />be palpable</p>\n</td>\n<td>Asymmetrical enlargement of few nerves</td>\n<td>Asymmetrical involvement of several nerves</td>\n<td><strong>Increasingly symmetric</strong> enlargement of nerves</td>\n<td>\n<p><strong>Symmetrical</strong><br /><strong>involvement</strong> of<br />nerve trunks with<br />‘<strong>glove and stocking</strong><br /><strong>anesthesia’</strong>.</p>\n<p>Nerves may feel normal on<br />palpation or may be<br />thickened.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Hair</strong></td>\n<td><strong>Absent</strong></td>\n<td>Markedly diminished</td>\n<td>Moderately diminished</td>\n<td>Slightly diminished</td>\n<td><strong>Almost normal (initially)</strong></td>\n</tr>\n<tr>\n<td><strong>Bacteriology on Split Skin Smear</strong></td>\n<td><strong>Negative</strong></td>\n<td>Negative or Scanty Bacilli</td>\n<td>Moderate number of AFB present</td>\n<td>Large number of AFB </td>\n<td>Plenty of AFB including <strong>Globi</strong> are seen</td>\n</tr>\n<tr>\n<td><strong>Typical Lepra Reaction</strong></td>\n<td>Type 1</td>\n<td>Type 1</td>\n<td>Type 1/Type 2</td>\n<td>Type 1/Type 2</td>\n<td>Type 2</td>\n</tr>\n<tr>\n<td><strong>Lepromin Reactivity</strong></td>\n<td>\n<p><strong>Strongly Positive</strong></p>\n<p>(+++)</p>\n</td>\n<td>\n<p>Weakly Positive</p>\n<p>(+ or ++)</p>\n</td>\n<td>Negative/ Weakly positive</td>\n<td>Negative</td>\n<td><strong>Negative</strong></td>\n</tr>\n<tr>\n<td><strong>Histopathology</strong></td>\n<td>\n<p><strong>Dermal Tuberculoid granulomas</strong> (arranged around nerves)</p>\n<p><strong>No bacilli are seen</strong></p>\n</td>\n<td>\n<p>Fewer Tuberculoid granulomas</p>\n<p><strong>Grenz clear zone</strong> in upper papillary dermis <strong>starts to form</strong></p>\n<p>Nerves are<br />replaced by granulomas</p>\n<p>Fragmented<br />bacilli are seen with AFB stain</p>\n</td>\n<td>\n<p>Tuberculoid granulomas less prominent</p>\n<p>Grenz zone is more prominent</p>\n<p>Transverse section of the nerve shows <strong>cut onion appearance</strong></p>\n</td>\n<td>\n<p>Prominent foam cells</p>\n<p>Prominent Grenz zone</p>\n<p>Nerves show concentric perineural cell infiltration<br />and <strong>more conspicuous cut onion appearance</strong>.</p>\n<p>AFB are plentiful, including<br /><strong>small globi</strong></p>\n</td>\n<td>\n<p><strong>Most prominent Grenz zone</strong></p>\n<p><strong>Expansive and loose granulomas</strong></p>\n<p>Plenty of macrophages<br />loaded with AFB- <strong>Virchow cells or Lepra cells</strong></p>\n<p>AFB are seen in endothelial cells and Schwann cells as clumps - <strong>globi</strong></p>\n<p>Nerves are minimally<br />involved.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Lepra Reactions</h3><p><strong>Lepra Reactions:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type 1 Reaction</strong></p>\n<p>(Reversal/Upgrading)</p>\n</td>\n<td>\n<p><strong>Type 2 Reaction</strong></p>\n<p>(Erythema Nodosum Leprosum)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mainly seen in the&nbsp;<strong>Borderline</strong> spectrum (BT, BB, BL)</p>\n<p><strong>Most severe</strong> in Borderline Lepromatous(BL) leprosy</p>\n</td>\n<td>Mainly seen in <strong>LL</strong>(50%)&gt;BL(15%)</td>\n</tr>\n<tr>\n<td>\n<p>Usually seen <strong>within 12 months</strong> of initiation of Multidrug Therapy</p>\n</td>\n<td><strong>Unrelated</strong> to Multidrug therapy. May occur before, during or after treatment</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type 4</strong> Hypersensitivity</p>\n<p>Due to <strong>enhanced cell-mediated response</strong>&nbsp;increased destruction of bacilli following treatment in reversal</p>\n</td>\n<td>\n<p><strong>Type 3</strong> Hypersensitivity</p>\n<p>Primarily Humoral</p>\n<p>(<strong>Immune complex Deposition</strong> in tissues and vessels)</p>\n<p>Cytokine involved - <strong>TNF-&alpha;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inflammation of <strong>existing skin lesions</strong> (red, painful edematous skin lesions) that may <strong>ulcerate</strong></p>\n<p>New lesions may occur (rare)</p>\n<p><strong>Neuritis</strong>&nbsp;and <strong>Nerve abscesses&nbsp;</strong>(red, painful inflamed nerves)</p>\n</td>\n<td>\n<p><strong>New, erythematous and tender</strong>, subcutaneous and dermal nodules that are widely distributed over extremities and face</p>\n<p>Existing lesions do not change</p>\n</td>\n</tr>\n<tr>\n<td><strong>No</strong> systemic involvement</td>\n<td><strong>Systemic symptoms</strong> present - fever, myalgias, arthralgias, anorexia, keratitis, iritis, nephritis, synovitis, orchitis, lymphadenopathy</td>\n</tr>\n<tr>\n<td>\n<p><strong>Treatment:</strong></p>\n<p>Supportive therapy for mild reactions with <strong>NSAIDs</strong></p>\n<p>In case of severe reactions with neuritis and eye lesions- <strong>Oral corticosteroids</strong></p>\n<p><strong>(Drug of Choice)</strong></p>\n<p>Nerve Abscess - Additional <strong>surgical drainage</strong></p>\n<p>Other drugs: Clofazimine, Cyclosporine</p>\n</td>\n<td>\n<p><strong>Treatment:</strong></p>\n<p><strong>Oral Corticosteroids - First-line drug<br /><br />Clofazimine </strong>(Steroid dependent ENL)<strong><br /></strong></p>\n<p><strong>Thalidomide -most effective </strong>but not used first due to various side effects</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: WHO proposed Multi Drug Therapy (MDT) for the treatment of Leprosy</h3><p><strong>WHO proposed Multi-Drug Therapy (MDT) for the treatment of Leprosy</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Age group</strong></p>\n</td>\n<td>\n<p><strong>Drug</strong></p>\n</td>\n<td>\n<p><strong>Duration of Treatment</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Adult</p>\n</td>\n<td>\n<p><strong>Rifampicin 600 mg</strong> once a month</p>\n<p>+</p>\n<p><strong>Clofazimine 300 mg</strong> once a month and <strong>50 mg daily</strong></p>\n<p>+</p>\n<p><strong>Dapsone 100 mg</strong> daily</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>12 months (MB)</p>\n<p>6 months (PB)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Children (10&ndash;14 years)</p>\n</td>\n<td>\n<p>Rifampicin <strong>450 mg</strong> once a month</p>\n<p>+</p>\n<p>Clofazimine <strong>150 mg</strong> once a month and 50 mg <strong>alternate days</strong>.</p>\n<p>+</p>\n<p>Dapsone <strong>50 mg</strong> daily&nbsp;</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>\n</td>\n<td>&nbsp;\n<p>12 months (MB)</p>\n<p>6 months (PB)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Children &lt;10 years old or &lt;40 kg</p>\n</td>\n<td>\n<p>Rifampicin <strong>10 mg/kg</strong> once a month</p>\n<p>+</p>\n<p>Clofazimine <strong>100mg</strong> once a month, 50mg <strong>twice weekly</strong></p>\n<p>+</p>\n<p>Dapsone <strong>2 mg/kg</strong> daily</p>\n</td>\n<td>\n<p>12 months (MB)</p>\n<p>6 months (PB)</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8c2d8461f7a54066a71c7b393a63be11.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5358",
      "difficulty": "medium"
    },
    {
      "text": "Chemoprophylaxis for leprosy should be given to which of the following persons?<div class='question-desc-html'><ol>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Contact of age more than 2 years</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Contact for more than 20 hours per week</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Sharing the same clothes, towels</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Living with a patient with leprosy for &gt;6 months</span></li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 4"
        },
        {
          "id": 2,
          "text": "1, 3, 4"
        },
        {
          "id": 3,
          "text": "2, 3, 4"
        },
        {
          "id": 4,
          "text": "1, 2, 3"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Chemoprophylaxis</strong> for leprosy should be given to <strong>contacts 1,2 </strong>and<strong> 4.</strong></p>\n<p>Chemoprophylaxis for leprosy should be given to the following contacts:</p>\n<ul>\n<li class=\"p1\">A person who has been in close contact with the index case for <strong>20 hours</strong> or more <strong>per week</strong> for <strong>more than 3 months</strong>.</li>\n<li class=\"p1\"><strong>Close contact</strong> if the <strong>age</strong> is more than <strong>2 years</strong></li>\n</ul>\n<p>The contact mentioned in option 4, is with the patient for more than 3 months. Therefore, even this contact will require chemoprophylaxis.</p>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Chemoprophylaxis cannot be given if there is/are:</span></p>\n<ul>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Possible signs of leprosy</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Signs or confirmed tuberculosis</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Liver or kidney disease</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Pregnancy</span></li>\n<li><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">Received rifampicin in the last 2 years</span></li>\n</ul>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Age more than 2 years&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">A <strong>single dose </strong>of<strong> rifampicin</strong> is used in chemoprophylaxis. Chemoprophylaxis must be initiated only 4 weeks after treatment for leprosy has begun in the patient so as to ensure the patient is non-infectious. </span></p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Dose of rifampicin in chemoprophylaxis of leprosy</strong></td>\n</tr>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Dose</strong></td>\n</tr>\n<tr>\n<td>Children 2-5 years</td>\n<td>10-15 mg/kg</td>\n</tr>\n<tr>\n<td>Children 6-9 years (less than 20kg)</td>\n<td>150 mg</td>\n</tr>\n<tr>\n<td>Children 6-9 years (more than 20kg)</td>\n<td>300 mg</td>\n</tr>\n<tr>\n<td>10-14 years</td>\n<td>450 mg</td>\n</tr>\n<tr>\n<td>15 years and above</td>\n<td>600 mg</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"p2\">&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4940",
      "difficulty": "medium"
    },
    {
      "text": "Match the following types of scales with their associated conditions.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Scales</strong></td>\n<td><strong>Lesion</strong></td>\n</tr>\n<tr>\n<td>1. Collarette scales</td>\n<td>a. Pityriasis versicolor</td>\n</tr>\n<tr>\n<td>2. Silvery scales</td>\n<td>b. Pityriasis rosea</td>\n</tr>\n<tr>\n<td>3. Mica-like scales</td>\n<td>c. Psoriasis</td>\n</tr>\n<tr>\n<td>4. Branny scales</td>\n<td>d. Pityriasis lichenoides</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-b, 2-c, 3-d, 4-a"
        },
        {
          "id": 2,
          "text": "1-a, 2-b, 3-d, 4-c"
        },
        {
          "id": 3,
          "text": "1-d, 2-c, 3-a, 4-b"
        },
        {
          "id": 4,
          "text": "1-c, 2-b, 3-d, 4-a"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correctly matched option is option A: 1-b, 2-c, 3-d, 4-a.</p><hr><h3>Related Pearl: Types of scales associated with dermatological conditions</h3><p><strong>Types of Scales and Associated Diseases</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type of Scale</strong></p>\n</td>\n<td>\n<p><strong>Associated Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Collarette scale</p>\n</td>\n<td>\n<p>It is a fine, peripherally attached, and centrally detached scale at the edge of an inflammatory lesion. It is seen in <strong>pityriasis rosea</strong>.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fish-like scales</p>\n</td>\n<td>\n<p>They are seen in <strong>ichthyosis</strong> <strong>vulgaris</strong> (<em><strong>ichthyos</strong></em>&nbsp;-&nbsp;<strong>fish</strong>). Ichthyotic scales are large and polygonal.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Silvery scales</p>\n</td>\n<td>\n<p>They are characteristic of processes involving parakeratosis, especially <strong>psoriasis</strong>. The silvery color is due to the reflection of light at several air&ndash;keratin interfaces.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mica-like scales</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 659\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>They are seen in <strong>Pityriasis lichenoides.&nbsp;</strong>The lesions are polymorphic with some showing hemorrhagic crusting and adherent scales.</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Yellow / greasy scales</p>\n</td>\n<td>\n<p>Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Leaf-like scales</p>\n</td>\n<td>\n<p>Pemphigus foliaceous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Powdery, branny, fine scales</p>\n</td>\n<td>\n<p>Pityriasis versicolor</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b6af559a05704578a2cf494258896e78x1280x8136.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4920",
      "difficulty": "easy"
    },
    {
      "text": "A 60-year-old patient presents with the lesion given in the image below. He also describes having the sensation of spiders crawling in the area of the lesion when he woke up. Which of the following is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Herpes zoster infection"
        },
        {
          "id": 2,
          "text": "Irritant contact dermatitis"
        },
        {
          "id": 3,
          "text": "Allergic contact dermatitis"
        },
        {
          "id": 4,
          "text": "Herpes simplex infection"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given image showing<strong>&nbsp;unilateral, red, grouped vesicles&nbsp;</strong>in a single<strong>&nbsp;dermatome</strong>&nbsp;associated with <strong>crawling sensation</strong> is highly<strong>&nbsp;</strong>suggestive of<strong>&nbsp;Herpes zoster infection.&nbsp;</strong></p>\n<p>Herpes zoster infection or <strong>shingles</strong> is a segmental eruption due to the&nbsp;<strong>reactivation</strong>&nbsp;of latent varicella-zoster virus from the&nbsp;<strong>dorsal root ganglia</strong>.&nbsp;An earlier infection with varicella is essential before zoster can occur.&nbsp;</p>\n<p>The first symptom&nbsp;of zoster is usually<strong>&nbsp;pain</strong>. It may also be accompanied by fever, headache, malaise, and tenderness localized to areas of one or more dorsal roots. The <strong>mucous membranes</strong> within the affected dermatomes are involved<strong>.</strong></p>\n<p>The patients are<strong>&nbsp;infectious</strong>, both from the virus in the lesions and the nasopharynx. The most commonly involved dermatomes in decreasing order of frequency are <strong>thoracic</strong> &gt; cervical &gt; <strong>trigeminal</strong> &gt; lumbosacral. The posterior nerve roots and ganglia show inflammatory changes.</p>\n<p>Zoster is a&nbsp;<strong>self‐limiting infection</strong>&nbsp;but it is painful and carries a risk of secondary infection and post‐herpetic neuralgia.&nbsp;<strong>Analgesia</strong>&nbsp;and treatment of secondary infections are sufficient for mild infections.</p>\n<p>Other options:&nbsp;</p>\n<p>Option B:<strong> Irritant contact dermatitis</strong>&nbsp;is the cutaneous response to the physical/toxic effects of a wide range of environmental exposures. The main clinical features are usually&nbsp;<strong>dryness</strong>&nbsp;or&nbsp;<strong>chapping</strong>. The lesions could commonly develop into patchy or diffuse erythema with&nbsp;<strong>scaling</strong>&nbsp;and&nbsp;<strong>fissuring</strong>.</p>\n<p>Option C: <strong>Allergic contact dermatitis</strong> is an&nbsp;<strong>eczematous reaction</strong>&nbsp;following&nbsp;<strong>exposure</strong>&nbsp;to a substance to which the immune system has previously been&nbsp;<strong>sensitized</strong>.&nbsp;</p>\n<p>Option D: <strong>Herpes simplex lesions</strong> are&nbsp;<strong>thin-walled, umbilicated vesicles,</strong>&nbsp;the roof of which breaks down, leaving tiny superficial&nbsp;<strong>ulcers.</strong>&nbsp;They heal without scarring.&nbsp;The most common site of cutaneous lesions in the face - is on the cheeks, chin, around the mouth, or on the forehead.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f8d7a5d1a5d64799b1f233491fa3e6b3.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4934",
      "difficulty": "easy"
    },
    {
      "text": "A 60-year-old diabetic female patient presents with progressive skin lesions, as shown in the image. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Squamous cell carcinoma"
        },
        {
          "id": 2,
          "text": "Basal cell carcinoma"
        },
        {
          "id": 3,
          "text": "Discoid lupus eryhtematosus"
        },
        {
          "id": 4,
          "text": "Melasma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The image above shows a <strong>central ulcer </strong>with<strong> raised borders </strong>and<strong> </strong>rolled-out edges (rodent ulcer) suggesting a diagnosis of <strong>basal cell carcinoma</strong>.</p>\n<p>Basal cell carcinoma is a <strong>slow-growing malignant tumor</strong> with <strong>locally invasive</strong> characteristics. It affects the pilosebaceous skin.</p>\n<p><strong>Ultraviolet radiation</strong> exposure is the <strong>strongest predisposing</strong> factor. Other risk factors include exposure to arsenic, coal tar, aromatic hydrocarbons, and ionizing radiation. </p>\n<p>Basal cell carcinoma mainly affects <strong>elderly</strong> or <strong>middle-aged men</strong> with excessive skin exposure, commonly in the age group of 40–80 y and in white-skinned people.</p>\n<p><strong>Macroscopically</strong>, it is categorized as localized and generalized. <strong>Nodular, nodulocystic </strong>(nodular and nodulocystic together account for 90% of basal cell carcinoma), pigmented, and nevoid are the localized cancers, while superficial multifocal and superficial spreading, infiltrative, and cicatrizing are the generalized types. The nodular type is described as <strong>pearly</strong> waxy <strong>nodules</strong> at the margins. A central depression (umbilication) or ulceration and rolled-out edges are characteristic of basal cell carcinoma.</p>\n<p>The below gross image shows pearly, rolled-out borders suggestive of basal cell carcinoma.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5a5f70a19ea9495894674d3b9581c4bfx720x761.JPEG\" alt=\"Explanation Image\"><p>Sites near the<strong> eye, nose, </strong>and<strong> ear</strong> and of size <strong>&gt;2 cm</strong> are considered to be<strong> high risk</strong>. Direct invasion at these sites can reach the cranium.</p>\n<p>Management is by <strong>Mohs microscopic surgery</strong>. Non-surgical measures, such as the administration of <strong>topical 5-fluorouracil</strong> and <strong>imiquimod,</strong> are useful. Metastasis is <strong>extremely rare.</strong></p>\n<p><strong>Other options:</strong></p>\n<p>Option A: <strong> Squamous cell carcinoma (SCC)</strong> is the second most common skin cancer. UV radiation exposure is the primary risk factor for SCC. Classically, it appears as a <strong>scaly or ulcerated papule or plaque</strong> that can <strong>bleed</strong> <strong>with minimal trauma, </strong>but the pain is rare. It can exhibit in situ (confined to the epidermis) or invasive subtypes. Wide surgical excision including subcutaneous fat is the treatment of choice for SCC.</p>\n<p>Option C:<strong> Discoid lupus erythe­matosus (DLE): </strong>DLE is typically located on the nose, cheeks, ear lobe, and concha. It may involve lips, oral mucosa, nose, or eyelids. Initial lesions of DLE are dry red patches, which then progress to<strong> indurated red or hyperpigmented plaques </strong>with adherent scale. Follicular keratosis (plugs of keratin within hair follicles) is observed when the surface scales are removed (carpet-tack sign). Older lesions are <strong>hyperpigmented</strong>, especially on the <strong>plaque</strong> <strong>edges. </strong>There is<strong> scarring</strong>, which results in <strong>central loss of pigment</strong>, white patches, and <strong>skin atrophy</strong>. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/526a9613bd5d4f59b4cdf695750d44c7x720x527.JPEG\" alt=\"Explanation Image\"><p>Option D: <strong>Melasma</strong> is the <strong>most common</strong> cause of <strong>facial melanosis</strong> that manifests as hyperpigmented macules on the face. It is exacerbated by <strong>sun exposure</strong> and <strong>oral contraceptive pills</strong>. The condition is predominantly seen in<strong> females</strong>. Melasma is very common in the <strong>3rd trimester</strong> of pregnancy and is most marked in brunettes. It occurs due to increased levels of<strong> estrogen</strong> and<strong> progesterone,</strong> stimulating the activity of melanocytes. It resolves on its own after pregnancy. Hypermelanosis affects mainly the upper lip, the malar regions, forehead, and the chin. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e337d287aabe440599fa0778b316dd1bx720x533.PNG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f7f305aaf267404e83dc1b7209ce4b2d.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7303",
      "difficulty": "easy"
    },
    {
      "text": "A diabetic patient presents with the following lesions in the armpit. Which of the following would be seen on Wood's lamp examination?",
      "choices": [
        {
          "id": 1,
          "text": "Yellow fluorescence"
        },
        {
          "id": 2,
          "text": "Coral red fluorescence"
        },
        {
          "id": 3,
          "text": "Blue fluorescence"
        },
        {
          "id": 4,
          "text": "Green fluorescence"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The image showing <strong>brown patches</strong> in <strong>axilla</strong> in a <strong>diabetic</strong> patient&nbsp;is suggestive of <strong>erythrasma</strong>.&nbsp;<strong>Coral‐red fluorescence</strong> under Wood&rsquo;s lamp is seen in erythrasma.</p>\n<p>Erythrasma is a skin infection caused by&nbsp;<strong><em>Corynebacterium minutissimum</em></strong>. It is common in&nbsp;<strong>diabetics</strong>&nbsp;and&nbsp;<strong>immunodeficient</strong>&nbsp;patients and is associated with&nbsp;<strong>obesity</strong>,&nbsp;<strong>sweating</strong>, and&nbsp;<strong>poor hygiene</strong>. It affects the&nbsp;<strong>axillae</strong>, groins, toe webs, inter-gluteal and submammary regions. Lesions may be symptomless or show mild discomfort and itching.</p>\n<p>The lesions may be of <strong>irregular shape</strong> with <strong>sharp margins</strong>. They may start as smooth, red patches and then become brown. The lesions are more likely to be <strong>pruritic</strong> in tropical regions and may be asymptomatic in a temperate climate.&nbsp;</p><p><strong>Coral‐red fluorescence</strong> with Wood&rsquo;s light is due to <strong>coproporphyrin III</strong> and suggests erythrasma. The fluorescence may persist after the eradication of the disease.&nbsp;</p>\n<p>Treatment of erythrasma is by using&nbsp;topical <strong>clotrimazole</strong>&nbsp;and&nbsp;<strong>miconazole</strong>&nbsp;for two weeks. For more extensive lesions,&nbsp;erythromycin&nbsp;can be administered. Relapse can occur. In such cases, long-term topical povidone-iodine application with drying agents can be used. Photodynamic therapy can also be attempted.&nbsp;</p>\n<p><strong>Green</strong>&nbsp;and blue-green fluorescence is seen in tinea capitis infections associated with microspora species and favus.</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\"><strong>Pityriasis versicolor</strong>&nbsp;is caused by&nbsp;<strong><em>Malassezia</em></strong>&nbsp;species&nbsp;and the typical lesions are&nbsp;asymptomatic&nbsp;<strong>hypopigmented or hyperpigmented</strong>&nbsp;macules and patches and produce&nbsp;<strong>fine scales</strong>.&nbsp;The&nbsp;<strong>color of the scales may vary</strong>&nbsp;from pale ochre to medium brown.&nbsp;<strong>Pale yellow&nbsp;</strong>fluorescence seen in&nbsp;<strong>Wood&rsquo;s lamp&nbsp;</strong>examination is<strong>&nbsp;characteristic</strong>&nbsp;of<strong>&nbsp;tinea versicolor&nbsp;</strong>or<strong>&nbsp;pityriasis versicolor.</strong>&nbsp;</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1275e24bddb244d598449d1640458a15x720x514.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6a3650814ef04cd3ab3b1cbb370f901ex1280x960.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Wood's lamp examination</h3><p><strong>Wood's lamp examination</strong> is a <strong>diagnostic</strong> test wherein the <strong>skin</strong> or <strong>hair</strong> is examined under exposure to the <strong>black</strong> <strong>light</strong> emitted by the <strong>Wood</strong> <strong>lamp</strong>.</p>\n<p>Blacklight is invisible to the naked eye because it is in the ultraviolet spectrum, with a wavelength just shorter than the color violet. The lamp glows violet in a dark environment because it also emits some light in the violet part of the electromagnetic spectrum.</p>\n<p>A traditional Wood lamp is a low-output mercury arc covered by a <strong>Wood</strong> <strong>filter</strong> (<strong>barium</strong> <strong>silicate</strong> and <strong>9% nickel oxide</strong>) and emits light at <strong>wavelength</strong> <strong>320</strong>–<strong>450</strong> <strong>nm</strong> (<strong>peak</strong> <strong>365</strong> <strong>nm</strong>).</p>\n<p><strong>Table</strong>: Various diseases and their color on Wood’s lamp examination</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Colour on Wood’s Light</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tinea capitis</p>\n<p> </p>\n</td>\n<td>\n<p><strong>Microsporum species</strong>: brilliant green (M. canis, M. audouinii, M. ferrugineum, M. distortum)</p>\n<p><strong>Trichophyton schoenleinii</strong>: dull blue</p>\n<p>Most <strong>Trichophyton </strong>species, with the exception of T. schoenleini<em>i</em>, are non-fluorescent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Erythrasma</p>\n</td>\n<td>\n<p>Coral pink</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pityriasis versicolor</p>\n</td>\n<td>\n<p>Faint yellow</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pseudomonas</p>\n</td>\n<td>\n<p>Green</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Scabies</p>\n</td>\n<td>\n<p>Fluorescein solution fills the burrows and fluoresces on Wood’s light.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Porphyria</p>\n</td>\n<td>\n<p>Urine, feces, blister fluid fluoresce red or pink</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitiligo</p>\n</td>\n<td>\n<p>Ivory or milky white</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2242a0f1720540909975b6853638f735x800x531.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/10f8f5323e3a4d049b708e0d234b7810.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7299",
      "difficulty": "easy"
    },
    {
      "text": "A 10-year-old boy is brought with weakness in his lower limbs and rash over the eyelids. The biopsy shows inflammation of the muscle. What is the finding shown in the image below?",
      "choices": [
        {
          "id": 1,
          "text": "Gottron's papules"
        },
        {
          "id": 2,
          "text": "Shawl sign"
        },
        {
          "id": 3,
          "text": "Heliotrope rash"
        },
        {
          "id": 4,
          "text": "Scleroderma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The finding shown in the image is&nbsp;<strong>Gottron's</strong>&nbsp;<strong>papules.</strong>&nbsp;The given scenario<strong>&nbsp;</strong>of a patient with weakness, rash, muscle inflammation, and presence of Gottron's papules on the skin is&nbsp;highly suggestive of<strong>&nbsp;dermatomyositis.</strong></p>\n<p><strong>Dermatomyositis</strong>&nbsp;(DM) is an autoimmune disorder predominantly affecting the&nbsp;<strong>skin</strong>&nbsp;and&nbsp;<strong>skeletal muscle</strong>. The following are various manifestations of dermatomyositis:</p>\n<ul>\n<li><strong>Proximal myopathy:</strong> Patients have trouble performing everyday activities like climbing stairs, getting up, and lifting their arms above their heads</li>\n<li><strong>Gottron's papules</strong>: Violaceous, erythematous papules overlying the dorsal interphalangeal or metacarpophalangeal, elbow, or knee joints, as shown in the image below</li>\n<li><strong>Gottron's sign</strong>: Symmetric, non-scaling, violaceous, erythematous macules or plaques, often atrophic, in the same distribution as Gottron's papules</li>\n<li><strong>Shawl sign</strong>/V-sign:&nbsp;Fixed macular erythema, across the shoulders and outer arms (Shawl distribution)</li>\n<li><strong>Periungual telangiectasias</strong>:&nbsp;Dilated capillaries of the nail folds</li>\n<li><strong>Mechanic's hand</strong>:<strong>&nbsp;</strong>Roughening and cracking of the skin of the tips and sides of the fingers, resulting in irregular, dirty-appearing lines that resemble those of a mechanic or manual laborer</li>\n<li>Less common manifestations include:&nbsp;Facial swelling, malignancy, erythroderma, lichen planus</li>\n</ul>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>Laboratory evaluation of patients with dermatomyositis will reveal&nbsp;<strong>elevated levels of serum creatine kinase</strong>&nbsp;and&nbsp;<strong>antinuclear antibodies</strong>. Electromyography will reveal features of myopathy. Histology will show&nbsp;<strong>perifascicular atrophy.</strong> Immunohistochemical staining will reveal&nbsp;<strong>myxovirus resistance protein A</strong>, a sensitive and specific marker.&nbsp;</p>\n<p>Treatment of dermatomyositis:</p>\n<ul>\n<li>Immunotherapy with&nbsp;<strong>high-dose glucocorticoids</strong>&nbsp;- first-line drug</li>\n<li><strong>Methotrexate</strong>&nbsp;-&nbsp;<strong>second-line</strong>&nbsp;drug; indications include the following\n<ul>\n<li>When the patient presents with severe weakness, or other organ system involvement</li>\n<li>Patients with a risk of steroid complications like patients with diabetes, osteoporosis, or postmenopausal women</li>\n<li>Patients who do not show improvement after 2&ndash;4 months of treatment with prednisone or those who cannot be maintained on a low dose&nbsp;</li>\n</ul>\n</li>\n<li><strong>Triple therapy</strong>&nbsp;with&nbsp;<strong>intravenous immunoglobulin&nbsp;</strong>or<strong>&nbsp;rituximab</strong>&nbsp;may be required</li>\n</ul>\n</div>\n</div><hr><h3>Related Pearl: Antibodies in Dermatomyositis</h3><ul>\n<li><strong>Anti-Mi2 antibodies</strong> (directed against a helicase implicated in nucleosome remodeling) show a strong association with prominent Gottron papules and heliotrope rash.</li>\n<li><strong>Anti-Jo1 antibodies</strong> (directed against the enzyme histidyl t-RNA synthetase) are associated with interstitial lung disease, nonerosive arthritis, and a skin rash described as &ldquo;mechanic&rsquo;s hands.&rdquo;</li>\n<li><strong>Anti-P155/P140 antibodies</strong> (directed against several transcriptional regulators) are associated with paraneoplastic and juvenile cases of dermatomyositis.</li>\n</ul><hr><h3>Related Pearl: Inflammatory myopathy</h3><table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Dermatomyositis</strong></td>\n<td><strong>Polymyositis</strong></td>\n<td><strong>Inclusion Body Myositis</strong></td>\n</tr>\n<tr>\n<td>Age of onset</td>\n<td>Adulthood and childhood</td>\n<td>&gt;18 years</td>\n<td>&gt;50 years  </td>\n</tr>\n<tr>\n<td>Familial Association</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Skin Manifestation</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Muscle involvement</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Asymmetric</p>\n</td>\n</tr>\n<tr>\n<td>Histopathological Findings</td>\n<td>\n<p><strong>Perimysial</strong> <strong>CD4+</strong> cellular infiltrates</p>\n<p>Perivascular infiltrates and <strong>perifascicular atrophy</strong></p>\n</td>\n<td>\n<p><strong>Endomysial</strong> <strong>CD8+</strong> cellular infiltrates </p>\n<p>Perivascular infiltrates  </p>\n</td>\n<td>\n<p><strong>Endomysial</strong> <strong>CD8+</strong> cellular infiltrates</p>\n<p>Perivascular infiltrates with amyloid inclusion bodies and rimmed vacuoles   </p>\n</td>\n</tr>\n<tr>\n<td>Association with connective tissue disease</td>\n<td>Scleroderma and mixed connective tissue only</td>\n<td>Yes</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Association with other autoimmune diseases</td>\n<td>Infrequent</td>\n<td>Frequent</td>\n<td> Infrequent</td>\n</tr>\n<tr>\n<td>Association with malignancy</td>\n<td>Yes (breast, ovarian, lung) and ILD</td>\n<td> Yes (incidence much lesser than dermatomyositis)</td>\n<td> No</td>\n</tr>\n<tr>\n<td>Immunotherapy</td>\n<td> Responsive</td>\n<td> Responsive</td>\n<td> Resistant</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/bcb0e241a34a48baa3c6a11321ce1702.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7301",
      "difficulty": "easy"
    },
    {
      "text": "Consider the causes of alopecia. Which among the following cause(s) non-scarring alopecia?<div class='question-desc-html'><p>1. Alopecia areata<br />2. Telogen effluvium<br />3. Androgenic alopecia<br />4. Frontal fibrosing alopecia</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "3 and 4"
        },
        {
          "id": 2,
          "text": "1, 2, and 3"
        },
        {
          "id": 3,
          "text": "2, 3, and 4"
        },
        {
          "id": 4,
          "text": "Only 4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Non-scarring alopecia is caused by androgenic alopecia, alopecia areata, and telogen effluvium (1, 2 and 3).&nbsp;&nbsp;<strong>Frontal fibrosing alopecia</strong> is&nbsp;a type of <strong>primary cicatricial (scarring) alopecia.</strong></p>\n<p><strong>Alopecia areata&nbsp;</strong>is a chronic inflammatory disease that causes&nbsp;<strong>non-scarring hair loss</strong>.&nbsp;It is a&nbsp;<strong>T-cell-mediated inflammatory disease.&nbsp;</strong>It is associated with several autoimmune diseases, including&nbsp;<strong>thyroiditis</strong>, lupus erythematosus<strong>,</strong>&nbsp;vitiligo, and psoriasis. It mainly affects the&nbsp;<strong>scalp,&nbsp;</strong>but can also affect the&nbsp;<strong>beard, eyebrows,&nbsp;</strong>and<strong>&nbsp;eyelashes.&nbsp;</strong>In some cases, this progresses to a total loss of scalp hair&nbsp;<strong>(alopecia totalis)</strong>&nbsp;or a loss of all hair on the body<strong>&nbsp;(alopecia universalis)</strong>.</p>\n<p><strong>Telogen effluvium</strong>&nbsp;is a type of<strong>&nbsp;nonscarring alopecia</strong>&nbsp;that is marked by&nbsp;<strong>diffuse</strong>&nbsp;<strong>shedding</strong>&nbsp;of normal hair. This occurs due to&nbsp;<strong>premature termination</strong>&nbsp;of the anagen phase of the hair cycle.&nbsp; It can be either acute or chronic.&nbsp;</p>\n<ul>\n<li><strong>Acute telogen effluvium</strong>&nbsp;occurs<strong>&nbsp;2&ndash;3 months</strong>&nbsp;after a stressful event such as high&nbsp;<strong>fever</strong>,&nbsp;<strong>surgery</strong>, starvation, and hemorrhage. Hormonal fluctuations during the&nbsp;<strong>postpartum</strong>&nbsp;period can trigger it (<strong>telogen gravidarum</strong>). Telogen effluvium can result in a diffuse reduction in hair density but never total baldness. It generally&nbsp;<strong>resolves</strong>&nbsp;<strong>spontaneously</strong>.&nbsp;</li>\n<li><strong>Chronic telogen effluvium</strong> is used to describe the diffuse shedding of telogen hair for more than<strong>&nbsp;6 months</strong>. Common causes include&nbsp;<strong>thyroid disorders</strong>, iron-deficiency anemia, and malnutrition.&nbsp;</li>\n</ul>\n<p><strong>Androgenetic alopecia </strong>is&nbsp;a disorder characterized by a reduction of hair fiber production by follicles and miniaturization. <strong>Dihydrotestosterone</strong>, an androgenic metabolite, is implicated in the etiology. It is of two types: male-pattern and female-pattern hair loss.&nbsp;Male-pattern hair loss causes <strong>frontal hairline recession</strong> and thinning of the <strong>vertex</strong>.&nbsp;&nbsp;Female-pattern hair loss involves the <strong>mid-frontal scalp</strong> diffusely. There is no or minimal involvement of the temporal region.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Causes of scarring and non-scarring alopecia- Mnemonic</h3><p>Alopecia or hair loss can be classified as :</p>\n<ol>\n<li>Non-Scarring/Non-Cicatricial alopecia</li>\n<li>Scarring/Cicatricial alopecia&nbsp;</li>\n</ol>\n<p><strong>Mnemonic</strong> for causes of<strong> non-scarring </strong>alopecia<strong>: THATS STD!</strong></p>\n<ul>\n<li><strong>T</strong>inea capitis(Non-Inflammatory Type&nbsp; - grey patch and black dot types )</li>\n<li><strong>H</strong>ormonal - Hypothyroidism, Androgenetic alopecia</li>\n<li><strong>A</strong>nagen effluvium,&nbsp;<strong>A</strong>lopecia areata</li>\n<li><strong>T</strong>richotillomania</li>\n<li><strong>S</strong>econdary syphilis (moth-eaten alopecia)</li>\n<li><strong>S</strong>LE(predominantly causes non-scarring alopecia but also can cause scarring alopecia)</li>\n<li><strong>T</strong>elogen effluvium</li>\n<li><strong>D</strong>eficiency of Zinc, Iron&nbsp;</li>\n</ul>\n<p><strong>Mnemonic</strong> for causes of <strong>scarring</strong> alopecia: <strong>SF<sub>2</sub>L<sub>3</sub></strong></p>\n<ul>\n<li><strong>S</strong>cleroderma - Linear scalp morphea (en coup de sabre)</li>\n<li><strong>F</strong>avus and Kerion (Inflammatory Type of Tinea capitis)</li>\n<li><strong>F</strong>olliculitis decalvans</li>\n<li><strong>L</strong>ichen planopilaris</li>\n<li><strong>L</strong>upus vulgaris</li>\n<li><strong>L</strong>upus erythematosis - discoid (DLE)</li>\n<li>Pseudopelade of Brocq</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7295",
      "difficulty": "easy"
    },
    {
      "text": "Match the following therapeutic methods used in the management of psoriasis with their possible side effects.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>Column A</td>\n<td>Column B</td>\n</tr>\n<tr>\n<td>1. PUVA</td>\n<td>a. Abortifacient</td>\n</tr>\n<tr>\n<td>2. Cyclosporine</td>\n<td>b. Effective but is highly nephrotoxic</td>\n</tr>\n<tr>\n<td>3. Methotrexate</td>\n<td>c. Long-term use increases the risk of skin cancer</td>\n</tr>\n<tr>\n<td>4. Acitretin</td>\n<td>d. Mucositis, teratogenic</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-c, 2-b, 3-a, 4-d"
        },
        {
          "id": 2,
          "text": "1-c, 2-a, 3-b, 4-d"
        },
        {
          "id": 3,
          "text": "1-b, 2-d, 3-c, 4-a"
        },
        {
          "id": 4,
          "text": "1-b, 2-c, 3-a, 4-d"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correctly matched pairs are as follows:</p>\n<table>\n<tbody>\n<tr>\n<td>Column A</td>\n<td>Column B</td>\n</tr>\n<tr>\n<td>1. PUVA</td>\n<td>c. Long-term use increases the risk of skin cancer</td>\n</tr>\n<tr>\n<td>2. Cyclosporine</td>\n<td>b. Effective but is highly nephrotoxic</td>\n</tr>\n<tr>\n<td>3. Methotrexate</td>\n<td>a. Abortifacient</td>\n</tr>\n<tr>\n<td>4. Acitretin</td>\n<td> d. Mucositis, teratogenic</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p><strong>PUVA</strong> is highly effective in clearing psoriasis with clearance rates of over 90%. It is associated with both acute (erythema, blistering) and chronic side effects. <strong>Long-term PUVA use</strong> is associated with the development of<strong> non-melanoma skin cancer</strong> (squamous cell cancer and basal cell cancer).</p>\n<p><strong>Cyclosporine</strong> is associated primarily with <strong>renal impairment</strong> (decreased GFR), metabolic disturbances, and an increased risk of malignancy. Due to its nephrotoxic effects, it is now uncommonly used for the maintenance of psoriasis.</p>\n<p>Both <strong>acitretin</strong> and methotrexate are <strong>teratogenic</strong>.</p>\n<p><strong>Acitretin</strong> is associated with dose-dependent mucocutaneous side effects (<strong>mucositis</strong>) and hyperlipidemia. To prevent retinoid-induced embryopathy, female patients should <strong>avoid conception</strong> for<strong> 3 years after discontinuing</strong> acitretin treatment. </p>\n<p>Acitretin is approved for use in the <strong>cutaneous</strong> manifestations of <strong>psoriasis.</strong></p>\n<p>Absolute contraindications:</p>\n<ul>\n<li>Pregnant women</li>\n<li>Women who are planning to conceive</li>\n<li>Breastfeeding</li>\n</ul>\n<p><strong>Methotrexate</strong> is also associated with <strong>mucositis</strong> and <strong>teratogenicity</strong>, it has been used as an <strong>abortifacient</strong> and is used in the management of molar pregnancies. Methotrexate is also associated with <strong>hepatotoxicity</strong>.</p><hr><h3>Related Pearl: Drug of choice for different types of psoriasis</h3><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Drug of choice</strong></td>\n</tr>\n<tr>\n<td>Chronic Plaque Psoriasis</td>\n<td>Methotrexate</td>\n</tr>\n<tr>\n<td>Erythrodermic Psoriasis</td>\n<td>Methotrexate&nbsp;</td>\n</tr>\n<tr>\n<td>Psoriatic Arthritis</td>\n<td>Methotrexate / Apremilast</td>\n</tr>\n<tr>\n<td>Pustular Psoriasis</td>\n<td>Acitretin</td>\n</tr>\n<tr>\n<td>Psoriasis in HIV patients</td>\n<td>Acitretin</td>\n</tr>\n<tr>\n<td>Impetigo Herpetiformis</td>\n<td>\n<p>1. Systemic Corticosteroids</p>\n<p>2. Cyclosporine</p>\n</td>\n</tr>\n<tr>\n<td>Erythrodermic Psoriasis in Pregnancy</td>\n<td>Systemic Corticosteroids&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7290",
      "difficulty": "easy"
    },
    {
      "text": "Skin manifestations caused by the drug administered for amebic dysentery are due to ______.",
      "choices": [
        {
          "id": 1,
          "text": "Fixed drug eruption"
        },
        {
          "id": 2,
          "text": "Urticaria"
        },
        {
          "id": 3,
          "text": "Maculopapular rash"
        },
        {
          "id": 4,
          "text": "Atopic dermatitis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The skin manifestations are most commonly due to&nbsp;<strong>metronidazole, </strong>which is associated with <strong>fixed drug eruption (FDE)</strong>.</p>\n<p>Although maculopapular rashes can also be seen with metronidazole, <strong>the incidence of a fixed drug eruption is higher with metronidazole.</strong></p>\n<p>Fixed drug eruptions/ reactions are characterized by&nbsp;<strong>sharply demarcated,</strong>&nbsp;<strong>dull red</strong>&nbsp;<strong>to brown</strong>&nbsp;lesions. They occur on lips, hands, legs, face, genitalia, and oral mucosa, and can cause a burning sensation. They are usually solitary or few in number and&nbsp;<strong>recur at the exact location</strong>. But, new lesions can occur on different body parts on re-exposure to the offending drug. <br /><br />FDE is a type of&nbsp;<strong>delayed hypersensitivity reaction</strong>. Paracetamol/NSAIDs are some of the most common drugs causing FDE.</p>\n<p>Drug‐specific clinical patterns of FDE include:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Drugs</strong>&nbsp;</td>\n<td><strong>Drug-specific clinical pattern of FDE</strong></td>\n</tr>\n<tr>\n<td>NSAIDs</td>\n<td>Lips and genitals</td>\n</tr>\n<tr>\n<td>Tetracycline/ Trimethoprim- sulfamethoxazole</td>\n<td>Genitals</td>\n</tr>\n<tr>\n<td>Metamizole</td>\n<td>Trunk and extremities</td>\n</tr>\n<tr>\n<td>Carbocysteine</td>\n<td>Face</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Diagnosis is based on history and lesion morphology.&nbsp;<strong>Discontinuation&nbsp;</strong>of the offending drug is the&nbsp;<strong>first step</strong>&nbsp;in&nbsp;<strong>management</strong>.</p>\n<p>The image below shows a <strong>well-defined hyperpigmented patch</strong> of a <strong>fixed drug eruption</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/345b549e83ab4455865cab5f24863b73x720x581.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Glossary of important skin lesions</h3><p><strong>Glossary of Important Skin Lesions</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lesion</strong></p>\n</td>\n<td>\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alopecia</strong></p>\n</td>\n<td>\n<p>Absence of hair from a normally hairy area</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Aphtha</strong></p>\n</td>\n<td>\n<p>A small ulcer of the mucosa</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Atrophy</strong></p>\n</td>\n<td>\n<p>Loss of tissue from one or more of the epidermis, dermis or subcutaneous tissues</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Burrow</strong></p>\n</td>\n<td>\n<p>A small tunnel in the skin that houses a parasite, such as the scabies acarus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Callus</strong></p>\n</td>\n<td>\n<p>A localized hyperplasia of the stratum corneum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cellulitis</strong></p>\n</td>\n<td>\n<p>An inflammation of cellular tissue, particularly purulent inflammation of the deep dermis and subcutaneous tissue</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Comedo</strong></p>\n</td>\n<td>\n<p>A plug of keratin and sebum in a dilated pilosebaceous orifice</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Crusts </strong><strong>(scabs)</strong></p>\n</td>\n<td>\n<p>Crusts consist of dried serum and other exudates</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cyst</strong></p>\n</td>\n<td>\n<p>Any closed cavity or sac (normal or abnormal) with an epithelial, endothelial or membranous lining and containing fluid or semi‐solid material</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Ecchymosis</strong></p>\n</td>\n<td>\n<p>A macular area of hemorrhage more than 1 cm (bruise) in diameter</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Erosion</strong></p>\n</td>\n<td>\n<p>A loss of epidermis, which heals without scarring. It commonly follows a blister.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Erythema</strong></p>\n</td>\n<td>\n<p>Redness of the skin produced by vascular congestion or increased perfusion</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Excoriation</strong></p>\n</td>\n<td>\n<p>Loss of skin substance, specifically produced by scratching</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Exfoliation</strong></p>\n</td>\n<td>\n<p>The splitting off of the epidermal keratin in scales or sheets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Fibrosis</strong></p>\n</td>\n<td>\n<p>The formation of excessive fibrous tissue</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Fissure</strong></p>\n</td>\n<td>\n<p>Any linear gap or slit in the skin surface</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Fistula</strong></p>\n</td>\n<td>\n<p>An abnormal passage from a deep structure, such as a hollow viscus, to the skin surface or between two structures</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Gangrene</strong></p>\n</td>\n<td>\n<p>Death of tissue, usually due to loss of blood supply</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Guttate lesions</strong></p>\n</td>\n<td>\n<p>Small round or oval lesions distributed as a &lsquo;shower&rsquo; of droplets. Usually applied to a form of psoriasis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hematoma</strong></p>\n</td>\n<td>\n<p>A localized tumor‐like collection of blood</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Keratoderma</strong></p>\n</td>\n<td>\n<p>A horny thickening of the skin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Lichenification</strong></p>\n</td>\n<td>\n<p>Thickening of the epidermis (and to some extent also of the dermis) in response to prolonged rubbing</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Macule</strong></p>\n</td>\n<td>\n<p>A flat circumscribed, non‐palpable lesion that differs in color from the surrounding skin. It can be of any color or shape. A macule is &lt;1 cm in diameter, larger lesions are a patch.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Maculopapular</strong></p>\n</td>\n<td>\n<p>Rash consisting of both macules and papules</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Milium</strong></p>\n</td>\n<td>\n<p>A tiny white cyst containing lamellated keratin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Nodule*</strong></p>\n</td>\n<td>\n<p>A solid palpable lesion in the dermis or subcutis, which can be observed as an elevation or can be palpated. It is &gt;0.5 cm in diameter.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Papule</strong></p>\n</td>\n<td>\n<p>An elevated solid lesion that is &lt;1 cm in diameter.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Petechia</strong></p>\n</td>\n<td>\n<p>A punctate hemorrhagic spot, approximately 1&ndash;2 mm in diameter.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Plaque</strong></p>\n</td>\n<td>\n<p>An elevated circumscribed lesion &gt;1 cm diameter; its surface is usually flat. Plaques may form from coalesced papules.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Poikiloderma</strong></p>\n</td>\n<td>\n<p>The association of cutaneous pigmentation, and telangiectasia.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pustule</strong></p>\n</td>\n<td>\n<p>A circumscribed lesion that contains purulent material.&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pyoderma</strong></p>\n</td>\n<td>\n<p>Any purulent skin disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scale</strong></p>\n</td>\n<td>\n<p>Scale is a flat plate or flake-like lesion desquamated of stratum corneum.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scar</strong></p>\n</td>\n<td>\n<p>Replacement by fibrous tissue of another tissue that has been destroyed by injury or disease</p>\n<p>An <strong>atrophic scar</strong> is thin and wrinkled.</p>\n<p>A <strong>hypertrophic scar</strong> is elevated, with excessive growth of fibrous tissue.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sclerosis</strong></p>\n</td>\n<td>\n<p>Diffuse or circumscribed induration of the subcutaneous tissues. It may also involve the dermis, when the overlying epidermis may be atrophic. It is characteristically seen in scleroderma.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sinus</strong></p>\n</td>\n<td>\n<p>A cavity or track with a blind ending</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Target lesions</strong></p>\n</td>\n<td>\n<p>These are &lt;3 cm in diameter and have three or more zones, usually a central area of dusky erythema or purpura, a middle paler zone of edema, and an outer ring of erythema with a well‐defined edge.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Tumor</strong></p>\n</td>\n<td>\n<p>Literally a swelling; the term is used to imply enlargement of the tissues by normal or pathological material, or cells that form a mass.&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Ulcer (of skin)</strong></p>\n</td>\n<td>\n<p>A loss of dermis and epidermis, often with loss of the underlying tissues</p>\n</td>\n</tr>\n<tr>\n<td><strong>Vesicles and Bullae</strong></td>\n<td>\n<p>&nbsp;A vesicle is a circumscribed elevation &lt;1 cm in diameter that contains fluid</p>\n<p>Bullae are &gt;1 cm in diameter</p>\n</td>\n</tr>\n<tr>\n<td><strong>Wheal</strong></td>\n<td>&nbsp;A transient elevation of the skin due to dermal and hypodermal, often pale centrally with an erythematous rim; it is the characteristic lesion of urticaria.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;*While Rook's textbook of Dermatology,9th edition mention nodule as &gt;0.5 cm. Some authors define nodules as &gt;1 cm.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7554",
      "difficulty": "easy"
    },
    {
      "text": "A 40-year-old man presents with erythematous painful lesions on the trunk and face, joint pain, and glove and stocking pattern of anesthesia. Which of the following investigations is used for the diagnosis of this condition?<div class='question-desc-html'><ol>\n<li>Nerve examination</li>\n<li>Skin biopsy</li>\n<li>Slit skin smear</li>\n<li>Mantoux test</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2"
        },
        {
          "id": 2,
          "text": "1, 2, 3"
        },
        {
          "id": 3,
          "text": "1, 3, 4"
        },
        {
          "id": 4,
          "text": "1, 2, 3, 4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical scenario points to a case of <strong>leprosy</strong>. The diagnosis of this condition requires nerve examination, skin biopsy, and a slit skin smear (option B- 1, 2, 3).</p>\n<p><strong>Leprosy</strong> is a chronic granulomatous condition caused by<em><strong> Mycobacterium leprae</strong></em>. It affects the skin, cutaneous and peripheral nerves, and mucous membranes.&nbsp;The most commonly affected peripheral nerves are the&nbsp;<strong>posterior tibial nerve</strong>, followed by the&nbsp;<strong>ulnar</strong>, median, and lateral popliteal nerves. The most commonly involved cranial nerve is the&nbsp;<strong>facial nerve</strong>.&nbsp;</p>\n<p>Leprosy has a <strong>long incubation</strong> period, usually ranging from 2 to 12 years. It commonly presents as an <strong>area of numbness</strong> on the skin or a visible skin lesion which could be a <strong>hypopigmented </strong>or <strong>erythematous macule</strong>. Lesions usually involve the face, extensor aspect of the limbs, trunks, and buttocks. The lesions have <strong>impaired nerve function</strong> and poor hair growth. The patients may also present with burns or ulcers of the anesthetic limb.</p>\n<p>Classification systems of leprosy:&nbsp;</p>\n<ul>\n<li><strong>Ridley-Jopling</strong> classification:\n<ul>\n<li>Tuberculoid (TT)</li>\n<li>Borderline tubercular (BT)</li>\n<li>Borderline (BB)</li>\n<li>Borderline lepromatous (BL)</li>\n<li>Lepromatous (LL)</li>\n</ul>\n</li>\n<li><strong>WHO</strong> classification:\n<ul>\n<li>Paucibacillary</li>\n<li>Multibacillary</li>\n</ul>\n</li>\n</ul>\n<p><strong>Cardinal signs</strong>&nbsp;for the diagnosis of leprosy:</p>\n<ul>\n<li>Characteristic <strong>skin lesions</strong>- hypopigmented or erythematous lesions with definite <strong>impairment of sensation.</strong></li>\n<li><strong>Peripheral nerve</strong> involvement- <strong>thickening</strong> of the nerve with sensory impairment. Nerve tenderness can also be seen.</li>\n<li>Detection of <strong>acid-fast bacilli</strong> in slit-skin smear, skin biopsy, or positive biopsy PCR.</li>\n</ul>\n<p>The presence of two of the three signs can establish the diagnosis of leprosy. Other tests done for diagnosis of leprosy include nerve biopsy in pure neural leprosy and PGL-1 antibody in cases with low bacterial load.</p><hr><h3>Related Pearl: Lepra Reactions</h3><p><strong>Lepra Reactions:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type 1 Reaction</strong></p>\n<p>(Reversal/Upgrading)</p>\n</td>\n<td>\n<p><strong>Type 2 Reaction</strong></p>\n<p>(Erythema Nodosum Leprosum)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mainly seen in the&nbsp;<strong>Borderline</strong> spectrum (BT, BB, BL)</p>\n<p><strong>Most severe</strong> in Borderline Lepromatous(BL) leprosy</p>\n</td>\n<td>Mainly seen in <strong>LL</strong>(50%)&gt;BL(15%)</td>\n</tr>\n<tr>\n<td>\n<p>Usually seen <strong>within 12 months</strong> of initiation of Multidrug Therapy</p>\n</td>\n<td><strong>Unrelated</strong> to Multidrug therapy. May occur before, during or after treatment</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type 4</strong> Hypersensitivity</p>\n<p>Due to <strong>enhanced cell-mediated response</strong>&nbsp;increased destruction of bacilli following treatment in reversal</p>\n</td>\n<td>\n<p><strong>Type 3</strong> Hypersensitivity</p>\n<p>Primarily Humoral</p>\n<p>(<strong>Immune complex Deposition</strong> in tissues and vessels)</p>\n<p>Cytokine involved - <strong>TNF-&alpha;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inflammation of <strong>existing skin lesions</strong> (red, painful edematous skin lesions) that may <strong>ulcerate</strong></p>\n<p>New lesions may occur (rare)</p>\n<p><strong>Neuritis</strong>&nbsp;and <strong>Nerve abscesses&nbsp;</strong>(red, painful inflamed nerves)</p>\n</td>\n<td>\n<p><strong>New, erythematous and tender</strong>, subcutaneous and dermal nodules that are widely distributed over extremities and face</p>\n<p>Existing lesions do not change</p>\n</td>\n</tr>\n<tr>\n<td><strong>No</strong> systemic involvement</td>\n<td><strong>Systemic symptoms</strong> present - fever, myalgias, arthralgias, anorexia, keratitis, iritis, nephritis, synovitis, orchitis, lymphadenopathy</td>\n</tr>\n<tr>\n<td>\n<p><strong>Treatment:</strong></p>\n<p>Supportive therapy for mild reactions with <strong>NSAIDs</strong></p>\n<p>In case of severe reactions with neuritis and eye lesions- <strong>Oral corticosteroids</strong></p>\n<p><strong>(Drug of Choice)</strong></p>\n<p>Nerve Abscess - Additional <strong>surgical drainage</strong></p>\n<p>Other drugs: Clofazimine, Cyclosporine</p>\n</td>\n<td>\n<p><strong>Treatment:</strong></p>\n<p><strong>Oral Corticosteroids - First-line drug<br /><br />Clofazimine </strong>(Steroid dependent ENL)<strong><br /></strong></p>\n<p><strong>Thalidomide -most effective </strong>but not used first due to various side effects</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Characteristics of Ridley Jopling Classification in Leprosy</h3><table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>TT (Tuberculoid Leprosy)</strong></td>\n<td><strong>BT (Borderline Tuberculoid)</strong></td>\n<td><strong>BB (Borderline)</strong></td>\n<td><strong>BL(Borderline Lepromatous)</strong></td>\n<td><strong>LL (Lepromatous Leprosy)</strong></td>\n</tr>\n<tr>\n<td><strong>Number and Type of lesions</strong></td>\n<td><strong>1-3</strong> <strong>well</strong><br /><strong>defined</strong> hypopigmented macule(s) or plaque(s) with elevated sloping borders '<strong>saucer right side up'</strong> lesion. Asymmetrical distribution.</td>\n<td>\n<p>Hypopigmented macules or plaques, variable in number, up to <strong>10</strong>.</p>\n<p>Occasionally showing fingerlike extensions<br />(<strong>pseudopodia</strong>) or <strong>satellite lesions</strong></p>\n</td>\n<td>\n<p>Hypopigmented macules or plaques with annular, ‘<strong>swiss </strong><strong>cheese’</strong> /inverted saucer/punched out appearance</p>\n<p>Variable in number<br /><strong>(10–30)</strong></p>\n</td>\n<td>\n<p><strong>Numerous</strong> hypopigmented macules, papules, plaques, and some nodules, lesions with <strong>swiss </strong><strong>cheese’</strong> /inverted saucer/punched out appearance <strong>almost symmetrical</strong> in<br />distribution</p>\n</td>\n<td>\n<p>Hypopigmented macules, plaques,<br />and nodular lesions</p>\n<p><strong>Innumerable</strong> lesions<br />showing <strong>perfect  symmetrical </strong>distribution</p>\n</td>\n</tr>\n<tr>\n<td><strong>Size of Lesion</strong></td>\n<td>Variable size,<strong>usually</strong><br /><strong>large</strong></td>\n<td>Variable size, some lesions are large</td>\n<td>Variable</td>\n<td>Variable, usually small</td>\n<td><strong>Small</strong></td>\n</tr>\n<tr>\n<td><strong>Surface of Lesion</strong></td>\n<td><strong>Dry, scaly and infiltrated</strong></td>\n<td>Dry, scaly infiltrated (but less than TT)</td>\n<td>Dry, scaly and slightly shiny</td>\n<td>Shiny (less than LL)</td>\n<td><strong>Shiny</strong></td>\n</tr>\n<tr>\n<td><strong>Sensations</strong></td>\n<td><strong>Absent. </strong></td>\n<td>Markedly diminished</td>\n<td>Moderately diminished</td>\n<td>Slightly diminished</td>\n<td><strong>May be normal</strong></td>\n</tr>\n<tr>\n<td><strong>Peripheral Nerves</strong></td>\n<td>\n<p><strong>Asymmetrical, single nerve</strong><br />enlargement.</p>\n<p>Nerve to patch may<br />be palpable</p>\n</td>\n<td>Asymmetrical enlargement of few nerves</td>\n<td>Asymmetrical involvement of several nerves</td>\n<td><strong>Increasingly symmetric</strong> enlargement of nerves</td>\n<td>\n<p><strong>Symmetrical</strong><br /><strong>involvement</strong> of<br />nerve trunks with<br />‘<strong>glove and stocking</strong><br /><strong>anesthesia’</strong>.</p>\n<p>Nerves may feel normal on<br />palpation or may be<br />thickened.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Hair</strong></td>\n<td><strong>Absent</strong></td>\n<td>Markedly diminished</td>\n<td>Moderately diminished</td>\n<td>Slightly diminished</td>\n<td><strong>Almost normal (initially)</strong></td>\n</tr>\n<tr>\n<td><strong>Bacteriology on Split Skin Smear</strong></td>\n<td><strong>Negative</strong></td>\n<td>Negative or Scanty Bacilli</td>\n<td>Moderate number of AFB present</td>\n<td>Large number of AFB </td>\n<td>Plenty of AFB including <strong>Globi</strong> are seen</td>\n</tr>\n<tr>\n<td><strong>Typical Lepra Reaction</strong></td>\n<td>Type 1</td>\n<td>Type 1</td>\n<td>Type 1/Type 2</td>\n<td>Type 1/Type 2</td>\n<td>Type 2</td>\n</tr>\n<tr>\n<td><strong>Lepromin Reactivity</strong></td>\n<td>\n<p><strong>Strongly Positive</strong></p>\n<p>(+++)</p>\n</td>\n<td>\n<p>Weakly Positive</p>\n<p>(+ or ++)</p>\n</td>\n<td>Negative/ Weakly positive</td>\n<td>Negative</td>\n<td><strong>Negative</strong></td>\n</tr>\n<tr>\n<td><strong>Histopathology</strong></td>\n<td>\n<p><strong>Dermal Tuberculoid granulomas</strong> (arranged around nerves)</p>\n<p><strong>No bacilli are seen</strong></p>\n</td>\n<td>\n<p>Fewer Tuberculoid granulomas</p>\n<p><strong>Grenz clear zone</strong> in upper papillary dermis <strong>starts to form</strong></p>\n<p>Nerves are<br />replaced by granulomas</p>\n<p>Fragmented<br />bacilli are seen with AFB stain</p>\n</td>\n<td>\n<p>Tuberculoid granulomas less prominent</p>\n<p>Grenz zone is more prominent</p>\n<p>Transverse section of the nerve shows <strong>cut onion appearance</strong></p>\n</td>\n<td>\n<p>Prominent foam cells</p>\n<p>Prominent Grenz zone</p>\n<p>Nerves show concentric perineural cell infiltration<br />and <strong>more conspicuous cut onion appearance</strong>.</p>\n<p>AFB are plentiful, including<br /><strong>small globi</strong></p>\n</td>\n<td>\n<p><strong>Most prominent Grenz zone</strong></p>\n<p><strong>Expansive and loose granulomas</strong></p>\n<p>Plenty of macrophages<br />loaded with AFB- <strong>Virchow cells or Lepra cells</strong></p>\n<p>AFB are seen in endothelial cells and Schwann cells as clumps - <strong>globi</strong></p>\n<p>Nerves are minimally<br />involved.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: WHO proposed Multi Drug Therapy (MDT) for the treatment of Leprosy</h3><p><strong>WHO proposed Multi-Drug Therapy (MDT) for the treatment of Leprosy</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Age group</strong></p>\n</td>\n<td>\n<p><strong>Drug</strong></p>\n</td>\n<td>\n<p><strong>Duration of Treatment</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Adult</p>\n</td>\n<td>\n<p><strong>Rifampicin 600 mg</strong> once a month</p>\n<p>+</p>\n<p><strong>Clofazimine 300 mg</strong> once a month and <strong>50 mg daily</strong></p>\n<p>+</p>\n<p><strong>Dapsone 100 mg</strong> daily</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>12 months (MB)</p>\n<p>6 months (PB)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Children (10&ndash;14 years)</p>\n</td>\n<td>\n<p>Rifampicin <strong>450 mg</strong> once a month</p>\n<p>+</p>\n<p>Clofazimine <strong>150 mg</strong> once a month and 50 mg <strong>alternate days</strong>.</p>\n<p>+</p>\n<p>Dapsone <strong>50 mg</strong> daily&nbsp;</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>\n</td>\n<td>&nbsp;\n<p>12 months (MB)</p>\n<p>6 months (PB)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Children &lt;10 years old or &lt;40 kg</p>\n</td>\n<td>\n<p>Rifampicin <strong>10 mg/kg</strong> once a month</p>\n<p>+</p>\n<p>Clofazimine <strong>100mg</strong> once a month, 50mg <strong>twice weekly</strong></p>\n<p>+</p>\n<p>Dapsone <strong>2 mg/kg</strong> daily</p>\n</td>\n<td>\n<p>12 months (MB)</p>\n<p>6 months (PB)</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7575",
      "difficulty": "medium"
    },
    {
      "text": "Identify the condition shown in the image below.",
      "choices": [
        {
          "id": 1,
          "text": "Paget disease"
        },
        {
          "id": 2,
          "text": "Lichen sclerosus"
        },
        {
          "id": 3,
          "text": "Lichen planus"
        },
        {
          "id": 4,
          "text": "Angioma of vulva"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image shows<strong>&nbsp;lichen sclerosus.</strong></p>\n<p>Lichen sclerosus usually presents in <strong>postmenopausal</strong> women. Multiple etiologies have been suggested (infectious, hormonal, genetic, and autoimmune). Symptoms include&nbsp;<strong>itching,&nbsp;</strong>excoriations, <strong>vulval skin thinning&nbsp;</strong>and crinkling,&nbsp;dysuria, and dyspareunia.&nbsp;<strong>Perianal</strong> involvement is frequently seen in the form <strong>figure of 8</strong> appearance.&nbsp;The typical appearance is&nbsp;<strong>white, atrophic papules</strong> may coalesce into plaques and distort normal anatomy. <strong>Labia minora regression</strong>, clitoral concealment, urethral obstruction, and introital stenosis can develop. A <strong>biopsy&nbsp;is needed to exclude malignancy</strong>.&nbsp;</p>\n<p><strong>Topical corticosteroids</strong> remain the first line of treatment.</p>\n<p>Premalignant lesions of vulva:</p>\n<ul>\n<li><strong>Vulvar intraepithelial neoplasia (VIN)</strong></li>\n<li><strong>Paget&rsquo;s disease</strong></li>\n<li>Lichen sclerosus</li>\n<li>Squamous cell hyperplasia</li>\n<li><strong>Condyloma accuminata</strong></li>\n<li><strong>Bowen&rsquo;s disease&nbsp;</strong>(erythroplasia of Queyrat)</li>\n</ul>\n<p><strong>Lichen planus</strong>&nbsp;is an inflammatory disorder affecting the skin and mucosal membranes. Nail involvement includes exaggeration of the longitudinal lines and linear depression. It<strong>&nbsp;</strong>manifests as <strong>6Ps</strong>&nbsp;pruritic, purple, polygonal, planar,&nbsp;<strong>papules,</strong>&nbsp;and&nbsp;<strong>plaques.</strong>&nbsp;It also exhibits&nbsp;<strong>Wickham striae&nbsp;</strong>(thin white lacy lines on the lesion)<strong>,&nbsp;</strong>and the&nbsp;<strong>Koebner phenomenon</strong>&nbsp;(new lesions at sites of skin trauma). <strong>Mucosal involvemen</strong>t is common including mouth and tongue, rarely it can also be found on the anus and genitalia</p>\n<p>The histological changes in <strong>lichen planus</strong> include increased Langerhans cells in the epidermis, <strong>spongiosis</strong>, and <strong>sawtooth appearance of Rete</strong> <strong>ridges</strong>. A fully developed lichen planus papule shows <strong>acanthosis</strong> of the epidermis, thickening of the granular layer, and hyperkeratosis. The image below shows the histopathological changes in lichen planus.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/78562cea9ae4445486f25c023794802fx510x496.GIF\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b473c6ad5d7f4ec89bfd80f8856d6950x1280x1187.JPEG\" alt=\"Explanation Image\"><p><strong>Vulvar Paget disease</strong> is an intraepithelial neoplasia that presents as an <strong>eczematoid, red, weeping area</strong> on the vulva. It is associated with invasive Paget disease or adenocarcinoma of the vulva or carcinoma at another non-vulvar location. It can be managed by local excision or vulvectomy. This condition needs long-term surveillance as recurrence is very common.</p>\n<p>&nbsp;</p><p><strong>Angioma of vulva&nbsp;</strong>- Hemangiomas and angiokeratomas are benign lesions of the vulva. Angiokeratomas are benign tumors characterized by hyperplasia of the epidermis along with multiple dilated vessels in the superficial dermis. They present as&nbsp;well-defined, <strong>erythematous, hyperkeratotic papules</strong>.&nbsp;Senile (cherry) hemangiomas usually present as red macules that rapidly progress to well-circumscribed, raised, red, and soft lesions. Excision biopsy of bleeding hemangiomas, cryosurgery, or carbon dioxide laser can be used for management.</p>\n<p>The image below shows a cherry angioma:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6843a34749634958860677650fb5808dx542x600.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/19964030afb84bc7bfea88478d210a5b.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7572",
      "difficulty": "medium"
    },
    {
      "text": "A patient comes to the OPD with the following skin manifestation of a disease associated with Raynaud phenomenon. What is the manifestation?",
      "choices": [
        {
          "id": 1,
          "text": "Poikiloderma"
        },
        {
          "id": 2,
          "text": "Salt and pepper pigmentation"
        },
        {
          "id": 3,
          "text": "Leukotrichia"
        },
        {
          "id": 4,
          "text": "Vitiligo"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical scenario is suggestive of <strong>systemic sclerosis</strong>, and the skin manifestation shown is a&nbsp;<strong>salt-and-pepper appearance</strong>.</p>\n<p>Systemic sclerosis is an <strong>autoimmune disease</strong> of unknown etiology, complex pathogenesis, and variable clinical presentations. It is associated with significant <strong>disability</strong> and <strong>mortality.</strong> Virtually every organ is affected.&nbsp;<strong>Thickened</strong> and <strong>indurated</strong> skin, called <strong>scleroderma</strong>, is the distinguishing hallmark of systemic sclerosis.</p>\n<div class=\"page\" title=\"Page 1523\">\n<div class=\"section\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Cutaneous features of systemic sclerosis:</p>\n<ul>\n<li><strong>Raynaud phenomenon</strong>, with the typical white discoloration of the fingers caused by <strong>vasospasm</strong> and bluish discoloration of the fingertips</li>\n<li>Loss of pigmentation except in the perifollicular areas is known as the salt and pepper appearance of the skin, which is mostly seen in the upper back, chest, and scalp</li>\n<li>Puffy fingers in early disease</li>\n<li><strong>Sclerodactyly</strong> and <strong>sclerosis</strong> extending proximal to the metacarpophalangeal joints with or without contractures&nbsp;</li>\n<li><strong>Vasculopathic ulcers</strong> over the bony prominences</li>\n<li>Loss of fingertip pulp</li>\n<li>Severe flexion contractures</li>\n<li>Facial features include <strong>expressionless facies,</strong> mat‐like telangiectases, microstomia, perioral furrowing, and a beak‐like nose&nbsp;&nbsp;</li>\n</ul>\n</div>\n</div>\n<div class=\"layoutArea\">&nbsp;</div>\n</div>\n<div class=\"section\">Other options:</div>\n<div class=\"section\">&nbsp;</div>\n<div class=\"section\">Option A: <strong>Poikiloderma</strong> is a skin disorder characterized by hypopigmentation and hyperpigmentation, wrinkling following atrophy, and telangiectasias. It is seen in ionizing radiation-damaged skin and dermatomyositis.</div>\n<div class=\"section\">&nbsp;</div>\n<div class=\"section\">Option C: The hair in the amelanotic lesions of vitiligo can sometimes lose color and become white. This is called <strong>leukotrichia.</strong></div>\n<div class=\"section\">&nbsp;</div>\n<div class=\"section\">Option D: <strong>Vitiligo</strong> is characterized by depigmented macules that have sharp demarcation. It is due to the loss of melanocytes.</div>\n</div>\n</div><hr><h3>Related Pearl: Diffuse Cutaneous Systemic Sclerosis  Versus Limited Cutaneous Systemic Sclerosis</h3><table>\n<tbody>\n<tr>\n<td><strong>Characteristic feature</strong></td>\n<td><strong>Diffuse cutaneous systemic sclerosis</strong></td>\n<td><strong>Limited cutaneous systemic sclerosis</strong></td>\n</tr>\n<tr>\n<td>Skin involvement</td>\n<td>\n<p>Rapid progression</p>\n<p>Involvement of the skin areas <strong>proximal</strong> <strong>to the knees or elbows</strong> or over the anterior chest, trunk, or abdomen</p>\n</td>\n<td>\n<p>Slow progression</p>\n<p>Limited to face and skin <strong>distal</strong> <strong>to the elbows and knees</strong></p>\n<p> </p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td>Raynaud’s phenomenon</td>\n<td>\n<p>Less severe</p>\n<p> </p>\n<p><strong>Short history</strong> </p>\n</td>\n<td>\n<p>More severe; commonly associated with critical limb ischemia.</p>\n<p><strong>Long history</strong> </p>\n</td>\n</tr>\n<tr>\n<td>Musculoskeletal</td>\n<td><strong>Severe arthralgia</strong>, carpal tunnel syndrome, and tendon friction rubs</td>\n<td><strong>Mild</strong> arthralgia</td>\n</tr>\n<tr>\n<td>Pulmonary manifestation</td>\n<td>Interstitial lung disease more common</td>\n<td>Pulmonary artery hypertension (PAH) is equal in both</td>\n</tr>\n<tr>\n<td>Scleroderma renal crisis</td>\n<td>Occurs usually &lt;4 years of disease onset</td>\n<td>Very rare</td>\n</tr>\n<tr>\n<td>Calcinosis cutis</td>\n<td>Less common</td>\n<td>More common &amp; prominent</td>\n</tr>\n<tr>\n<td>Auto-antibodies</td>\n<td>\n<p><strong>Anti-topoisomerase I</strong> (Scl-70)</p>\n<p>anti-RNA polymerase III</p>\n</td>\n<td><strong>Anti centromere</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/35bb13425bb64e78b9164796e0c2fc29x1280x2412.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Manifestations of systemic sclerosis</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Organ</strong></p>\n</td>\n<td>\n<p><strong>Manifestations</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skin</p>\n</td>\n<td>\n<p>Endothelial injury and microvascular disease causing chronic ischemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alimentary Tract</p>\n</td>\n<td>\n<p>Affected in approximately 90% of patients.</p>\n<p>Progressive atrophy and collagenous fibrous replacement of the muscular is most severe in the esophagus.</p>\n<p><strong>The lower two-thirds of the esophagus often develops a rubber-hose&ndash;like an inflexibility. </strong></p>\n<p>Gastroesophageal reflux and Barrett metaplasia and strictures.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Musculoskeletal System</p>\n</td>\n<td>\n<p>Hypertrophy and hyperplasia of the synovial soft tissues</p>\n<p><strong>Joint destruction is not common</strong> in systemic sclerosis.</p>\n<p>Inflammatory myositis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kidneys.</p>\n</td>\n<td>\n<p><strong>The most prominent are the vascular lesions.</strong></p>\n<p>Interlobular arteries show intimal thickening as a result of deposition of mucinous or finely collagenous material</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lungs.</p>\n</td>\n<td>\n<p>The lungs are involved in more than 50% of individuals</p>\n<p>Pulmonary hypertension and interstitial fibrosis</p>\n<p>Pulmonary fibrosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heart</p>\n</td>\n<td>\n<p>Pericarditis with effusion, myocardial fibrosis, and thickening of intramyocardial arterioles</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e40a46c6a08c44e7ad65d4cdb56db86cx1280x853.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/3f8fbb147d334ed5907f39c38c61c3b8.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7547",
      "difficulty": "easy"
    },
    {
      "text": "A  female patient came to the hospital with a history of relapsing, remitting, mildly itchy erythematous plaques over the scalp, sacral area, and knees. She has a  history of joint pain and her nail changes are shown in the image below. What is your diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Adult onset Still's disease"
        },
        {
          "id": 2,
          "text": "Pachyonychia congenita"
        },
        {
          "id": 3,
          "text": "Psoriasis"
        },
        {
          "id": 4,
          "text": "Lichen planus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The diagnosis in this patient with the above clinical features is <strong>psoriasis.</strong></p>\n<p>The image shows&nbsp;<strong>nail pitting, oil drop sign,&nbsp;</strong>and&nbsp;<strong>salmon patches </strong>in fingernails</p>\n<div class=\"page\" title=\"Page 1141\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>Psoriasis is a chronic inflammatory condition of the skin with systemic manifestations. The skin lesions can have <strong>exacerbations</strong> and <strong>relapse.</strong> They include <strong>red</strong>, <strong>silvery-white</strong>&nbsp;<strong>well-demarcated scales.</strong> A peripheral clearing known as the <strong>ring of Woronoff</strong> may be present. It is usually seen on the <strong>scalp</strong>, <strong>trunk</strong>, and <strong>extensor surfaces</strong> of the limbs. The appearance of a smooth, glossy red membrane with small bleeding points on the removal of the supra-papillary epidermis by gentle scraping is known as&nbsp;<strong>Auspitz's sign.</strong></p>\n<p><strong>Psoriatic arthritis</strong> presents as&nbsp;<span>early morning stiffness and joint swelling, heel pain due to enthesitis of the Achilles tendon, or plantar fasciitis. The clinical</span><span>&nbsp;examination may reveal evidence of dactylitis (sausage fingers) or swollen or tender joints.</span>&nbsp;The distal interphalangeal joint (DIP) is classically involved in causing <strong>pencil-in cup</strong> deformity.</p>\n</div>\n</div>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p><strong>Punctate pitting</strong> is the most common nail finding and others include the&nbsp;<strong>oil-drop sign</strong>,&nbsp;subungual hyperkeratosis, splinter haemorrhages, and <strong>distal onycholysis</strong>.</p>\n<p>The topical application of <strong>steroids</strong>, retinoids, vitamin D, and <strong>emollients</strong> is the mainstay of management. <strong>Phototherapy</strong> and oral <strong>methotrexate</strong>, <strong>acitretin</strong>, and cyclosporine are used for more extensive and systemic diseases.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Nail changes in psoriasis</h3><p><strong>Nail changes in psoriasis</strong> are present in about<strong>&nbsp;40%&nbsp;</strong>of the cases at any point in time. Nail psoriasis is associated with more&nbsp;extensive&nbsp;psoriasis, longer disease duration,&nbsp;family history&nbsp;of psoriasis, and the presence of&nbsp;psoriatic arthritis.</p>\n<p><strong>Subungal oil drop sign or Salmon Patch</strong>&nbsp;is a<strong>&nbsp;highly specific&nbsp;</strong>pathognomonic sign seen in Nail psoriasis. It is a yellow-red discoloration in the nail bed resembling a drop of oil.</p>\n<p><strong>Nail pitting</strong>&nbsp;however is the most<strong>&nbsp;frequent sign.&nbsp;</strong>Individual pits are uniformly sized,&nbsp;<strong>deep and irregular</strong>&nbsp;in nature. These nail pits are also known as <strong>Thimble pits</strong>&nbsp;and are due to the involvement of the proximal nail matrix.</p>\n<p>Nail Bed disease also causes&nbsp;<strong>subungual hyperkeratosis</strong>,&nbsp;<strong>splinter hemorrhages,</strong>&nbsp;and&nbsp;<strong>distal onycholysis</strong>.</p>\n<p><strong>Leuconychia</strong>&nbsp;may also be present.</p>\n<p><strong>Trachonychia</strong>&nbsp;or Twenty Nail dystrophy may be present in severe cases.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f0da378ee7f743efbfc9081ff7287a61x512x340.PNG\" alt=\"Pearl Image\"><p>Image :&nbsp;&nbsp;Pitting is the commonest manifestation of nail psoriasis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f09a662cc05e4c4f995a7ee68a24d4bbx512x334.PNG\" alt=\"Pearl Image\"><p>Image:&nbsp;oil drops visible in the nail bed.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3aa273571f484fe380d4efe7476efa4ex512x348.PNG\" alt=\"Pearl Image\"><p>Image:&nbsp;pitting and salmon patches in fingernails.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b553a94f74764bffb051362172637611x512x341.PNG\" alt=\"Pearl Image\"><p>Image:&nbsp;Leukonychia in a patient with psoriasis.</p>\n<p>&nbsp;</p>\n<p><strong>Features of Nail Psoriasis &ndash; Mnemonic</strong></p>\n<p>&ldquo;Nail &ndash; <strong>POLISH</strong>&rdquo;</p>\n<ul>\n<li><strong>P &ndash; P</strong>itting</li>\n<li><strong>O &ndash; O</strong>il drop sign<strong>, O</strong>nycholysis</li>\n<li><strong>L &ndash; L</strong>euconychia</li>\n<li><strong>I &ndash; I</strong>rregular pitting pattern</li>\n<li><strong>S &ndash; S</strong>plinter Hemorrhage</li>\n<li><strong>H &ndash; H</strong>yperkeratosis (Subungual)</li>\n</ul><hr><h3>Related Pearl: Nail findings and associated systemic conditions</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Nail finding</strong></p>\n</td>\n<td><strong>Associated systemic condition</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Clubbing</strong></p>\n</td>\n<td>\n<ul>\n<li>Inflammatory bowel disease</li>\n<li><span>Lung cancer</span></li>\n<li>Idiopathic pulmonary fibrosis</li>\n<li><span>Complicated tuberculosis</span></li>\n<li><span>Suppurative lung disease (lung abscess, empyema, bronchiectasis, cystic fibrosis)</span></li>\n<li>Mesothelioma</li>\n<li>Cirrhosis</li>\n<li>Congenital heart disease, Endocarditis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Koilonychia</strong></p>\n</td>\n<td>\n<p>Iron-deficiency anemia, hemochromatosis, Raynaud&rsquo;s disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Onycholysis</strong></p>\n</td>\n<td>\n<p>Psoriasis, onychomycosis, hyperthyroidism, sarcoidosis, trauma, amyloidosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pitting</strong></p>\n</td>\n<td>\n<p>Psoriasis, Reiter&rsquo;s syndrome, Alopecia areata</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Beau&rsquo;s lines</strong></p>\n</td>\n<td>\n<p>Any severe systemic illness that disrupts nail growth, Raynaud&rsquo;s disease, pemphigus, trauma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Yellow nail</strong></p>\n</td>\n<td>\n<p>Lymphedema, pleural effusion, immunodeficiency, bronchiectasis, sinusitis, rheumatoid arthritis, nephrotic syndrome, thyroiditis, tuberculosis, Raynaud&rsquo;s disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Nail Pterygium</strong></p>\n</td>\n<td>\n<p>Dorsal: Lichen Planus</p>\n<p>Ventral: trauma, systemic sclerosis, Raynaud phenomenon, lupus erythematosus</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"heading\">&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Nail finding</strong></p>\n</td>\n<td>\n<p><strong>Associated systemic condition</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Terry&rsquo;s (white) nails</strong></p>\n</td>\n<td>\n<p>Hepatic failure, cirrhosis, diabetes mellitus, CHF, hyperthyroidism, malnutrition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Azure lunula</strong></p>\n</td>\n<td>\n<p>Hepatolenticular degeneration (Wilson&rsquo;s disease), silver poisoning, quinacrine therapy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Half-and-half nails</strong></p>\n</td>\n<td>\n<p>Specific for renal failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Muehrcke&rsquo;s lines</strong></p>\n</td>\n<td>\n<p>Specific for hypoalbuminemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mees&rsquo; lines</strong></p>\n</td>\n<td>\n<p>Arsenic poisoning, Hodgkin&rsquo;s disease, CHF, leprosy, malaria, chemotherapy, carbon monoxide poisoning, other systemic insults</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Dark longitudinal streaks</strong></p>\n</td>\n<td>\n<p>Melanoma, benign nevus, chemical staining, normal variant in darkly pigmented people</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Splinter hemorrhage</strong></p>\n</td>\n<td>\n<p>Subacute bacterial endocarditis, SLE, rheumatoid arthritis, antiphospholipid syndrome, peptic ulcer disease, malignancies, oral contraceptive use, pregnancy, psoriasis, trauma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Telangiectasia</strong></p>\n</td>\n<td>\n<p>Rheumatoid arthritis, SLE, dermatomyositis, scleroderma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d9bd6517e74a4f0ea85b34e5c1da6437.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7556",
      "difficulty": "easy"
    }
  ]
}